Additional Defined Terms. The following terms shall have the meanings set forth on the pages of this Agreement indicated below: 280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g) Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)

Appears in 1 contract

Sources: Agreement and Plan of Merger (Myriad Genetics Inc)

Additional Defined Terms. ~~The~~ For purposes of the Agreement, the following terms shall have the meanings ~~set forth on~~ defined in the ~~pages of this~~ Section indicated: Acquired Assets 2.1(b) Acquired Personal Property 2.1(b)(vii) Affiliate Lease Agreement ~~indicated below: 280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~3.2(f) Agreement ~~Preamble~~ preamble [***] Collaboration Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~recitals Assignment and Assumption and ▇▇▇▇ of Sale 3.2(i) ~~Audited Balance Sheet 3.9(b~~Assumed Liabilities 2.3(b) ~~Audited Balance Sheet Date 3.9(b~~AZ Documents 4.2 AZ Indemnified Parties 9.3 AZ Parties preamble AZCV preamble [***] Collaboration recitals [***] Collaboration Programs recitals [***] Collaboration Programs Assignment and Novation recitals AZUK preamble Basket 9.5(a) ~~Audited Financial Statements 3.9(b~~Clinical Supply Agreement 3.2(c) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Closing ~~2.4~~ 3.1 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~3.1 Cellective Diligence Terms 7.10(b)(iii) ~~Company Preamble Company Board~~ Cellective Merger Agreement 7.10(a) Cellective Milestone Terms 7.10(b)(i) Cellective Representative 7.10(a) Common Stock 1.1 Competing Activities 7.9(a) Confidential Information 7.2 Development Services Agreement 3.2(e) De Minimis Amount 9.5(a) DFCI 7.11(a) DFCI License Agreement 7.11(a) Dispute Period 9.4(b) Duke 7.11(a) Duke License Agreement 7.11(a) Excluded Assets 2.2(b) Excluded Liabilities 2.4(b) [***] License Agreement 7.12(a) [***] License Term Sheet 7.12(a) FTC 4.4(k) Governmental Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a4.3(b) Indemnified ~~D&Os 6.4(a~~Party 9.1 Indemnifying Party 9.1 Investors recitals License Agreement 3.2(g) MedImmune, Inc. 7.10(a) Medi LLC preamble Medi Ltd recitals MRC Payment Agreements 3.2(h) Non-assignable Asset 2.5 Parties preamble Party preamble Payee 10.4 Payment 10.4 Programs recitals Purchase Price 1.1 Restricted Period 7.9(a) Retained Contract 10.4 Securities Purchase Agreement recitals Services Agreement 3.2(j) Spinco preamble Spinco Business recitals Spinco Indemnified Parties ~~10.1(a~~9.2(a) ~~Interim Balance Sheet 3.9(b~~Sublicense Agreements 3.2(d) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Survival Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii9.1 ▇▇▇▇▇▇ 7.10(a) ▇▇▇▇▇▇ ~~Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a~~Consulting Agreement 7.10(a) Third Party Claim ~~10.4(b~~9.4(b) ~~Working Capital Deficit 2.17(f~~Transferred Employees 7.5(a) ~~Working Capital Objection Period 2.17(e~~Transition Services Agreement 3.2(b) ~~Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~WARN Act 2.4(b)(ii)

Appears in 1 contract

Sources: Asset Purchase Agreement (Viela Bio, Inc.)

Additional Defined Terms. ~~The~~ In addition to the terms defined in Section 1.01, the following terms ~~shall have~~ are defined in the ~~meanings set forth on the pages~~ corresponding Section of this ~~Agreement indicated below: 280G Approval 6.3(c~~Agreement. Term Section Accounting Firm 3.03 (b) ~~280G Payments 6.3(c~~Accounts Receivable 5.05 (f) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Escrow Account 2.06 (a) Adjustment Escrow Amount 2.05 (a)(i) Adjustment Escrow Shortfall 2.06 (b)(ii) Agreement Preamble ~~Agreement Date~~ Asset Purchase 2.02 Asset Seller Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b)~~ Audited Balance Sheet Date ~~3.9(b~~5.05 (a) Audited Financial Statements ~~3.9(b~~5.05 (a) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iiiAuthorized Action 12.15 (c) ▇▇▇▇▇ ~~Law 3.12(b~~4.06 Business Recitals Business Intellectual Property 5.12 (a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Buyer Preamble Buyer Disclosure Schedules Article 6 Buyer Indemnified Persons 11.02 Buyer Plans 8.02 (b) ~~Straddle~~ Buyer Return 8.04 (b) Claims 8.05 (c) Closing 3.01 Closing Date 3.01 Closing Date Balance Sheet 3.03 (a) Company(ies) Recitals Company Benefit Plans 5.17 (a) Company Data 5.12 (h) Company Disclosure Schedules Article 5 Company Employees 5.16 (a) Company Indemnified Parties 8.03 (a) Company Intellectual Property 5.12 (a) Company Subsidiaries 5.04 (a) Company Subsidiary Interests 5.04 (a) Company Systems 5.12 (f) Continuing Company Employee 8.02 (a) Data Policies 5.12 (i) Defense Notice 11.05 (a) Disclosing Party 8.05 (d) D&O Tail Policy 8.03 (c) EAR 5.24 (b) Equity Interests Recitals Equity Purchase 2.01 Equity Sellers Preamble Escrow Agent 2.05 (a)(i) Escrow Agreement 2.05 (a)(i) Escrow Amount 2.05 (a)(i) Estimated Closing Purchase Price 2.04 Estimated Closing Statement 2.04 Excluded Persons 8.06 (c) Existing Policies 11.06 (f) Final Closing Cash 3.03 (b) Final Closing Date Statement 3.03 (a) Final Closing Indebtedness 3.03 (b) Final Closing Working Capital 3.03 (b) Final Purchase Price 3.03 (b) Final Seller Transaction Expenses 3.03 (b) Financial Statements 5.05 (a) Former Holder 12.15 (b) ▇▇▇▇▇▇▇ ▇▇▇▇ 12.14 (a) Indemnity Escrow Account 2.06 (a) Indemnity Escrow Amount 2.05 (a)(i) Indemnified Party 11.04 (a) Indemnifying Party 11.04 (a) Individual Breach 11.02 Insurance Policies 5.19 Interim Balance Sheet Date 5.05 (a) Interim Financial Statements 5.05 (a) IRS 5.17 (d) Lease 5.10 (a) Leased Real Property 5.10 (a) Material Contracts 5.13 (a) Material Customers 5.22 (a) Material IP Agreements 5.12 (a) Material Suppliers 5.22 (b) Multiemployer Plan 5.17 (a) Non-U.S. Benefit Plan 5.17 (a) Notice of Disagreement 3.03 (b) Party(ies) Preamble Payoff Letters 3.02 (a)(vii) Post-Closing Seller Employee Bonus Payments 8.04 (h) Privileged Communications 12.14 (a) Prop 65 5.23 (f) Purchase Price 2.03 (a) Receiving Party 8.05 (d) Registered Intellectual Property 5.12 (a) Releasee 8.05 (c) Releasor 8.05 (c) Representatives 6.09 Restricted Period ~~1.1 Subsidiary Securities 3.2(b~~8.06 (c) ~~Survival Date 10.3(a~~Sales Tax Proceedings 8.04 (j)(i) Security Incident 5.12 (k) Seller Disclosure Schedules Article 4 Seller Group 12.14 (a) Seller Indemnified Persons 11.03 Seller Return 8.04 (a) Seller Transaction Expenses Certificate 3.02 (a)(xvii) Sellers Preamble Sellers’ Representative 12.15 (a) Senior Employee Agreements Recitals State Sales Tax Liabilities 8.04 (j) State Sales Tax Liability Proceedings 8.04 (j)(i) Successor Holder 12.15 (b) Tax Escrow Account 2.06 (a) Tax Escrow Amount 2.05 (a)(i) Territory 8.06 (c) Third ~~Party~~ Person 11.05 (a) Third Person Claim ~~10.4(b~~11.05 (a) ~~Working Capital Deficit 2.17(f~~Transaction Expenses 12.01 (a) ~~Working Capital Objection Period 2.17(e~~VCG Assignment and Assumption Agreement 3.02 (a)(ii) ~~Working Capital Objection Statement 2.17(e~~VDA 8.04 (j) ~~Working Capital Surplus 2.17(f)~~VDA Proceeding 8.04 (j) Vionic Entities Recitals Vionic Group Recitals Vionic International Recitals Warrant Cancellation Agreement Recitals Weil Recitals

Appears in 1 contract

Sources: Equity and Asset Purchase Agreement (Caleres Inc)

Additional Defined Terms. ~~The~~ For purposes of this Agreement, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Accounting Firm 3.4(b) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Adjustment Event 3.6 Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Applicable Fund GAAP 5.20(e) ~~Audited Balance Sheet 3.9(b~~Barrack Privilege Parties 2.1(b)(vi) ~~Audited Balance Sheet Date 3.9(b~~Basket 10.4(a) ~~Audited Financial Statements 3.9(b~~Benchmark Cumulative FFO 3.5(a)(i) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a~~Business Intellectual Property 5.16(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) CAH License Agreement ~~3.16(a)(xi~~4.2(a)(iv) ~~License Agreements 3.16(a)(xi~~Cap 10.4(a) ~~Majority Effective Time Holders 9.1(c~~CC Preamble CC Adviser 5.21(a) ~~Measurement Date 1.1 Merger~~ CC Assumed Liabilities 2.1(c) CC Consolidated Entities 5.12(a) CC Contributed Assets 2.1(a) CC Contribution Closing 2.1(a) CC Disclosure Letter 5 CC Holdings Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) CC Pre-Closing Contribution 2.1(a) CC Retained Assets 2.1(b) CC Retained Liabilities 2.1(d) CC Transferred Books and Records 2.1(a)(iv) CCH Preamble CFI Preamble CFI Assumed Liabilities 2.2(c) CFI Board Recitals CFI Contributed Assets 2.2(a) CFI Contribution Closing 2.2(a) CFI Credit Agreement 2.2(c) CFI Disclosure Letter 6 CFI GP Investments 3.5(a)(iii) CFI Indemnified Parties 10.3 CFI Pre-Closing Contribution 2.2(a) CFI Privilege Parties 2.1(b)(vi) CFI Retained Assets 2.2(b) CFI Retained Liabilities 2.2(d) CFI Stockholders Meeting 7.8(b) Change of Recommendation 7.9(a) Claim 10.5(a) Closing 4.1 Closing Date 4.1 Colony ▇▇▇▇ Transfer Agreement Recitals Consideration 3.1 Contingent Consideration 3.1 Contingent Consideration Account 3.5(b) Contingent Consideration Dispute Period ~~6.1 Preliminary~~ 3.5(f) Contingent Consideration Statement 3.5(e)(iii) Contingent Consideration Statements 3.5(e)(iii) Contribution 3.1 Contributor Preamble Contributor Indemnified Parties 10.2 Contributors Preamble CRM Recitals CRM CRP Interests Recitals CRM Interests Recitals CRM Investment Management Agreement 4.2(a)(ii) CRP Recitals CRP Interests Recitals D&O Tail 7.11(b) Disbursement Schedule 3.2(a)(i) Dispute Notice 3.4(b) Estimated CC Closing ~~Balance Sheet 2.17(a~~Adjustment 3.2(a)(ii) ~~Preliminary~~ Estimated CC Closing Cash Consideration 3.2(a)(ii) Estimated CC Closing Date Cash 3.2(a)(ii) Estimated CC Closing Share Consideration 3.2(a)(ii) Estimated CC Closing Unit Consideration 3.2(a)(ii) Estimated CC Closing Unpaid Indebtedness 3.2(a)(ii) Estimated CC Working Capital 3.2(a)(ii) Estimated CCH Closing Unit Consideration 3.2(a)(ii) Estimated CFI Common Stock Count 3.2(a)(ii) Estimated CFI Series A Preferred Stock Count 3.2(a)(ii) Estimated CFI Series B Preferred Stock Count 3.2(a)(ii) Estimated Closing Consideration 3.2(a)(ii) Estimated Closing Statement ~~2.17(a~~3.2(a)(ii) ~~Prior Merger~~ Estimated CRP Closing Adjustment 3.2(a)(ii) Estimated CRP Closing Date Cash 3.2(a)(ii) Estimated CRP Closing Unpaid Indebtedness 3.2(a)(ii) Estimated CRP Working Capital 3.2(a)(ii) Estimated FHB Closing Cash Consideration 3.2(a)(ii) Estimated FHB Closing Unit Consideration 3.2(a)(ii) Estimated ▇▇▇▇▇▇▇▇ Closing Cash Consideration 3.2(a)(ii) Estimated ▇▇▇▇▇▇▇▇ Closing Unit Consideration 3.2(a)(ii) FFO Additional Contingent Consideration Amount 3.5(a)(iv) FFO Additional Contingent Payment Units 3.5(a)(v) FFO Contingent Consideration Amount 3.5(a)(vi) FFO Contingent Consideration Statement 3.5(e)(ii) FFO Contingent Payment Units 3.5(a)(vii) FFO Lower Threshold 3.5(a)(viii) FFO Measurement Period 3.5(a)(x) FFO Target 3.5(a)(x) FHB Preamble Final CC Closing Adjustment 3.4(b) Final CC Closing Cash Consideration 3.4(b) Final CC Closing Date Cash 3.4(b) Final CC Closing Share Consideration 3.4(b) Final CC Closing Unit Consideration 3.4(b) Final CC Closing Unpaid Indebtedness 3.4(b) Final CC Working Capital 3.4(b) Final CCH Closing Unit Consideration 3.4(b) Final Closing CFI Common Stock Count 3.4(b) Final Closing Consideration 3.4(b) Final Closing Series A Preferred Stock Count 3.4(b) Final Closing Series B Preferred Stock Count 3.4(b) Final Closing Statement 3.4(b) Final CRP Closing Adjustment 3.4(b) Final CRP Closing Date Cash 3.4(b) Final CRP Closing Unpaid Indebtedness 3.4(b) Final CRP Working Capital 3.4(b) Final FHB Closing Cash Consideration 3.4(b) Final FHB Closing Unit Consideration 3.4(b) Final ▇▇▇▇▇▇▇▇ Closing Cash Consideration 3.4(b) Final ▇▇▇▇▇▇▇▇ Closing Unit Consideration 3.4(b) Financial Statements 5.12(a) Fund Financial Statement 5.20(e) Government Entity 5.22(b) Independent Directors 3.5(e)(i) Interests 6.5(c) Leased Real Property 5.17(a) Material Contracts 5.14(a) New Shares 3.3(b)(ii) New Units 3.3(b)(i) NewCo Preamble NewCo Interests Recitals Non-RE Capital Raise Contingent Consideration Statement 3.5(e)(iii) Non-RE Capital Raise Contingent Payment Units 3.5(c)(iii) Non-RE Capital Raise Target 3.5(a)(xi) Non-RE Cumulative Capital Raise 3.5(a)(xiii) Notice of Disagreement 3.5(f) OP Preamble OP LLC Agreement ~~Preamble Related Agreements 3.5(a~~4.2(a)(v) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Payment Due Date 10.6(f) ~~Specified Representations 10.2(a)(iii~~Per Claim Threshold 10.4(a) Personal Information 5.23 Post-Closing Statement 3.4(a) Privacy Policy 5.23 Proxy Statement 7.8(a) Qualified Third-Party Capital 3.5(a)(xiv) RE Capital Raise Additional Contingent Consideration Amount 3.5(a)(xv) RE Capital Raise Additional Contingent Payment Units 3.5(a)(xvi) RE Capital Raise Contingent Consideration Amount 3.5(a)(xvii) RE Capital Raise Contingent Consideration Statement 3.5(e)(i) RE Capital Raise Contingent Payment Units 3.5(a)(xviii) RE Capital Raise Lower Threshold 3.5(a)(xix) RE Capital Raise Measurement Period 3.5(a)(xx) RE Capital Raise Target 3.5(a)(xxi) RE Cumulative Capital Raise 3.5(a)(xxii) Real Property Leases 5.17(a) Recommendation 6.2(b) REIT 6.8 Requisite CFI Stockholder Approvals 6.2(a) Requisite Charter Amendment Stockholder Approvals 6.2(a) Requisite Issuance Stockholder Approvals 6.2(a) Review Period 3.4(b) Routine Examination 5.9(a) ▇▇▇▇▇▇▇▇ ~~Law 3.12(b~~Preamble Share Retention Notice 7.21(b) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Shared Communications 2.1(b)(vi) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a)~~ Special Committee Recitals Third Party Claim ~~10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~10.6(a)

Appears in 1 contract

Sources: Contribution and Implementation Agreement (Colony Financial, Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Defined Term Section Additional Disclosure 10.8 Adjustment Calculation 2.6(a) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Notice 2.6(a) Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Business Leader 5.9(b) ~~Audited Balance Sheet 3.9(b~~Cap 9.6(c) ~~Audited Balance Sheet Date 3.9(b~~Certain Countries 3.19(g) ~~Audited Financial Statements 3.9(b~~Claim Notice 9.3(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Closing ~~2.4~~ 2.3(a) Closing Consideration 2.2 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~2.3(a) Company Preamble Company ~~Board Approval 3.5 Company Certificate 2.10(e~~Intellectual Property 3.13(a) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Consideration Shares 2.2 Controlling Party 9.4(d) ~~Company Preferred Stock 2.10(b~~Covered Matter 5.18 De Minimis Claims 9.6(a) ~~Company Representative 5.11 Company Software 3.18(l~~Deductible 9.6(b) ~~Company Third Party Consents 6.3(b~~Dispute 10.11(a) ~~Company Warrant 2.14(a~~Defined Term Section Dispute Meeting 10.11(a) ~~Company Warrant Documents 2.12(a~~Dispute Notice 2.6(b) ~~Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~Dresser-Rand Group Preamble Effective Date Preamble Employment Agreements 2.4(a) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(fExpert 2.6(f) Escrow Agent ~~2.16~~ 2.5 Escrow Agreement ~~2.16~~ 2.5 Escrow ~~Fund 2.16 Estimated Working Capital Surplus 2.17(b~~Amount 2.5 Fespyme 5.14(b) ~~FDA Requirements 3.19(a~~Financial Statements 3.5(a) ~~Final Working Capital 2.17(e~~Foton 5.15(a) ~~Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Foton Companies 5.15(a) Indemnified ~~D&Os 6.4(a~~Party 9.3(a) Indemnifying Party 9.3(a) Indemnity Deriving from Arbitration 5.15(h) Independent Accounting Firm 2.6(d) Leased Real Property 3.12(a) Long-Stop Date 7.1(g) Member of Management 5.18 Noncontrolling Party 9.4(d) Objection Notice 9.3(b) Owned Intellectual Property 3.13(a) Owned Real Property 3.12(a) parties Preamble party Preamble Permitted Activities 5.15(e) Public Deed 2.3(c) Purchase Price 2.6(j) Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 9.1 Restricted Period 5.7 Restricted Persons 5.6(a) SEC Reports 4.7 Securities Act 3.28(a) Seller Disclosure Schedule Article 3 Seller Releases 2.4(a) Seller Representative 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Sellers Preamble ~~Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent~~ Shares Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Supplemental Disclosure 10.8 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(aClaims 9.4(c) Third Party Claim ~~10.4(b~~9.4(a) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Third Party Intellectual Property 3.13(b)

Appears in 1 contract

Sources: Share Purchase Agreement (Dresser-Rand Group Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ Defined Term Section Agreed ~~Claims 10.4(g~~Portion 10.3(b) Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Applicable D&O Claim 10.5(e) ~~Audited~~ Applicable Escrow Final Indian Tax Reimbursement Shortfall 10.3(g)(iii) Applicable Escrow/Setoff Final Indian Tax Reimbursement Shortfall 10.3(g)(iii) Applicable Excess 10.3(g)(ii) Asserted Losses 10.3(a) Assumed Option 6.11 Assumed Option Exercise Price 6.11 Assumed Option Holder 6.11(a)(i) Assumed Option Spread Value Per Share 6.11(a)(ii) Balance Sheet ~~3.9(b~~4.5(a)(i) ~~Audited Balance Sheet Date 3.9(b~~Block Trade 3.9(c) ~~Audited Financial Statements 3.9(b~~Certificate 3.3(a)(i) California ~~Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Commissioner 4.3 Change in Recommendation 6.9(b) Charter Amendment 6.19 Closing ~~2.4~~ 2.2 Closing Date ~~2.4~~ 2.2 Closing Date Net Working Capital ~~Estimate 2.17(a~~Statement 3.6(c) Closing Disbursement 2.2(c)(ii) COBRA 4.16(c) Company Preamble Company Board ~~Approval 3.5 Company Certificate 2.10(e~~Recommendation 6.9(a) Company Disclosure Schedule ~~3.0~~ Article 4 Company ~~Disclosure Schedules 3.0~~ Indemnified Parties 10.2 Company ~~Option 2.13(a~~Intellectual Property 4.13(a) Company ~~Preferred Stock 2.10(b~~Materiality Qualified Provisions 10.1 Company Representatives 6.5(a) Company ~~Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a~~Specified Representations 10.5(a) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8~~ 6.6(a) Contingent Assumed Option 6.11(a)(iii) Contingent Payment Amounts 6.11(b) Contractors 4.17(b) Controlling Party 10.3(e) D&O ~~Cap 6.4(b~~Indemnified Parties 6.17(a) ~~Delivered Tax Returns 3.22(a~~De Minimis Amount 10.5(c) Deposit 9.4(d) DGCL ~~Preamble Disclosure Statement 5.8(a~~2.1 Disputed Line Items 3.8(b) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~3.5 DOL 4.16(b) (a) Earn-Out Shares 3.1(c) Earn-Out Statement 3.7(a) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~2.2(a) ~~Employee Plan 3.15(h~~Employment Agreement Preamble End Date 8.1(b) ~~Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~Escrow Account 2.2(c)(i) Escrow Agent ~~2.16~~ 2.2(c)(i) Escrow Agreement ~~2.16~~ 2.2(c)(i) Escrow ~~Fund 2.16~~ Final Indian Tax Reimbursement 10.3(g)(iii) Escrow Shares 2.2(c)(i) Estimated Amount 10.3(g)(ii) (a) Estimated Net Working Capital ~~Surplus 2.17(b~~Statement 3.6(a) ~~FDA Requirements 3.19(a~~Exchange Agent 2.2(c)(ii) Exchange Agent Agreement 2.2(c)(ii) Expense Reimbursement 8.3(a)(ii) Fairness Approval 6.8(b) Fairness Hearing 6.8(b) Final Closing Net Working Capital 3.6(d) Final Indian Tax Amount 10.3(g)(ii) Final Net Working Capital Shortfall Reimbursement Amount 3.6(d)(ii) Final Working Capital ~~2.17(e~~Payment Amount 3.6(d)(i) Financial Statements 4.5(a) Firm ~~11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii)~~ 11.16 Holder Representative Preamble Holder Representative Agreement 11.5 HSR Act ~~6.2(a~~4.3 Indemnification Demand 10.3(a) Indemnified ~~D&Os 6.4(a~~Party 10.3(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 10.3(a) Independent Accounting Firm 3.8(c) Indian Proceeding 10.3(g)(i) Indian Proceeding Amount 10.3(g)(i) Indian Proceeding Notice 10.3(g)(i) Information Statement 6.8(a) Interim Balance Sheet ~~3.9(b~~4.5(a)(ii) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~Intervening Event 6.9(c)(ii) Leased Real Property ~~3.14(a~~4.12(a) ~~Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi~~Lock-Up Restriction 3.9(c) Majority Effective Time Holders ~~9.1(c~~11.1(b) ~~Measurement Date 1.1~~ Malicious Code 4.13(j) Merger 2.1 Merger Sub Preamble Multiemployer Plan 4.16(c) New Health Plans 6.18(b) New Plans 6.18(b) Non-Contingent Assumed Option ~~Cancellation Agreement 2.13(c~~6.11(a)(iv) ~~Organizational Documents 3.3 Out~~Non-~~of-the-Money Company Option 2.13(b~~Releasable Options 6.11(d) ~~Out-of-the-Money Company Warrant 2.14(b~~Notice of Disagreement 3.8(b) ~~Outside Date 8.1(b~~Old Health Plans 6.18(b) ~~Parent~~ Original Vesting Requirements 6.11 Parties Preamble ~~Parent Closing Balance Sheet 2.17(c~~Pension Plan 4.16(b) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c~~Permit Application 4.3 Presented Values 3.8(a) ~~Parent Working Capital Statement 2.17(c~~Price Ratio 6.11(a)(v) ~~Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement~~ Purchaser Preamble ~~Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii)~~ Purchaser Disclosure Schedule Article 5 Purchaser Indemnified Parties 10.1 Purchaser Materiality Qualified Provisions 10.2 Purchaser Specified Representations ~~10.2(a)(iii~~10.5(b) Qualified Plan 4.16(b) Qualifying Royalty Revenue Period 3.7(a) Qualifying Royalty Revenues 3.7(a) Registration Statement 4.3 Reimbursed Indian Taxes 10.3(g)(iv) Releases 2.2(b)(i)(B) Representative Losses 11.1(d) Response 10.3(b) Retention Plan Participant List 6.22 ▇▇▇▇▇▇▇▇-▇▇▇▇▇ ~~Law 3.12(b~~Act 5.6(a) Scheduled Release Date(s) 6.11(c) SEC Reports 5.6(a) Seller Group 11.16 Setoff Amount 10.3(g)(ii) Share Ratio 6.11(a)(vi) Stockholder Approval ~~3.8~~ Requirements 6.13 Stockholder ~~Meeting 5.8(b~~Vote 4.2 Subsequent Monthly Financial Statements 6.15 Surviving Corporation 2.1 Tax Contest 9.4(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a~~Termination Fee 8.3(b) Third Party ~~Claim 10.4(b~~Claims 10.3(e) ~~Working Capital Deficit 2.17(f~~Third Party Intellectual Property 4.13(c) ~~Working Capital Objection Period 2.17(e~~Threshold 10.5(c) ~~Working Capital Objection Statement 2.17(e~~Title IV Plan 4.16(c) ~~Working Capital Surplus 2.17(f~~Transfer 3.9(c) Transfer Taxes 9.3 Transmittal Documentation 3.3(a)(i) Transmittal Letter 3.3(a)(i) Trillium Contracts 3.7(a) Unsatisfied Amount 10.3(g)(ii) Voting Agreements Preamble Withholding Agents 3.10(a)

Appears in 1 contract

Sources: Merger Agreement (Radisys Corp)

Additional Defined Terms. The following terms ~~shall~~ have the ~~meanings~~ meaning assigned to such terms in the Sections of the Agreement set forth ~~on the pages of this Agreement indicated~~ below: ~~280G Approval 6.3(c~~Accounting Firm 2.6 Acquisition Transaction Recitals Aggregate Earnout Period 2.5(a) ~~280G Payments 6.3(c~~Allowable Grace Period 5.15(a)(vi) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Annual Earnout Period 2.5(a) Agreement ~~Preamble~~ Introductory Paragraph Asset Purchase Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited~~ Recitals Balance Sheet ~~3.9(b~~3.5(a) ~~Audited~~ Balance Sheet Date ~~3.9(b~~3.5(a) ~~Audited~~ Base Purchase Price 2.2(a)(i) Basic Earnout 2.5(b) Benefit Plans 3.16(b) Bonus Earnout 2.5(b) ClearOne Introductory Paragraph Closing 2.7 Closing Adjustment Statement 2.5 Closing Payment Amount 2.2(b) Direct Claim 8.5(c) 11 Earnout Payment Statement 2.5(b) Escrow Fund 2.3 Escrow Payment 2.5(a) Estimated Net Assets Statement 2.2(a)(ii) Effectiveness Deadline 5.15(a) Filing Deadline 5.15(a) Financial Statements ~~3.9(b~~3.5(a) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Foreign IP Transaction Recitals Fundamental Representations ~~10.2(a)(ii~~8.1 HK Note Recitals HK Purchaser Recitals Inadvertent Termination Ruling 5.5(h) ~~HSR Act 6.2(a~~Inadvertent Termination Ruling Request 5.5(h) Indemnification Period 8.1 Indemnified ~~D&Os 6.4(a~~Party 8.5 Indemnifying Party 8.5 Initial Net Asset Adjustment Amount 2.2(a)(ii) ~~Indemnified~~ Lease Transaction Recitals Material Contracts 3.13 Material Customers 3.21(a) Material Suppliers 3.21(b) Net Asset Adjustment Amounts 2.2(a)(ii) Party or Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Introductory Paragraph Pre-Closing Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a~~5.6 Purchase Price Adjustment 5.5(d) ~~Preliminary Closing~~ Purchase Price 2.2(a) Purchaser Introductory Paragraph Purchaser’s Agents 5.15(g)(ii) Purchaser Indemnitees 8.2 Quarterly Earnout Period 2.5(b) Real Estate Entity Recitals Registration Expenses 5.15(a)(iv) Registration Statement ~~2.17(a~~5.15(a) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Registration Termination Date 5.15(a) Registry Recitals Sabine Recitals Sabine Business Recitals Sabine Database 3.12(h) Sabine Net Revenue Schedule 2.4(d) Section 338(h)(10) Election 5.5(d) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Introductory Paragraph Seller’s Agents 5.15(g)(i) ~~Specified Representations 10.2(a)(iii~~Selling Expenses 5.15(a)(iv) ~~▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a~~Shares Recitals Statement of Objections 2.6 Tax Adjustment 5.5(d) Third Party Claim ~~10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~8.5(a)

Appears in 1 contract

Sources: Stock Purchase Agreement (Clearone Inc)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below~~: 280G Approval 6.3(c~~. 401(k) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Plan 6.10 Action of Divestiture 6.6 Agreement Preamble ~~Agreement~~ Applicable Expiration Date ~~Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~8.1(a) ~~Audited Balance Sheet 3.9(b) Audited~~ Balance Sheet Date ~~3.9(b~~3.7 Certificate of Incorporation 3.1(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8~~ Certificate of Merger ~~2.4 Claims 10.4 CLIA 1.1~~ 2.3 Charter Amendment 2.5(a) Charter Documents 3.1(a) China RoHS 1.1(oo) Claim Certificate 8.4(a) Closing ~~2.4~~ 2.2 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a)~~ 2.2 Company Preamble Company ~~Board Approval 3.5~~ Authorizations 3.19 Company ~~Certificate 2.10(e~~Indemnitees 6.16(a) Company Participants 6.9 Company Privacy Policy 3.15(m)(i) Company Source Code 3.15(l) Company Stock Certificates 2.9(b)(iv) Conflict 3.5 Consent Fees 6.7(a) Continuing Employees 6.9 Copyrights 1.1(hhh) Current Balance Sheet 3.7 D&O Tail Policy 6.16(c) Deductible 8.3(b) Defense Notice 8.5 Delaware Law 2.1 Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(aArticle III Dissenting Share Payments 2.8(c) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~2.8(a) Domain Names 1.1(hhh) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~2.3 Escrow Fund 8.6(a) Escrow ~~Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b~~Period 8.6(b) ~~FDA Requirements 3.19(a~~Excess Expenses and Fees 6.11 Exchange Act 4.8(a) ~~Final Working Capital 2.17(e~~Exchange Documents 2.9(b)(iv) ~~Firm 11.9 FTC 6.2(a~~Expiration Date 8.1(a) ~~Fundamental Representations 10.2(a)(ii~~FCL 3.29(g) ~~HSR Act 6.2(a~~Financials 3.7 FIRPTA Compliance Certificate 6.14 Indemnified Parties 8.2(a) Indemnified ~~D&Os 6.4(a~~Party 8.2(a) ~~Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b~~Information Statement 6.1(a) In-~~the-Money Company Option 2.13(a~~Licenses 3.15(e)(i) ~~In-the-Money Company Warrant 2.14(a~~Intellectual Property Contracts 3.15(e)(i) Interim Escrow Disbursement Date 8.6(b) Interim Financials 3.7 Lease Agreements 3.14(b) Leased Real Property 3.14(a) Letter ~~Amendment Premable Letter~~ of Transmittal ~~2.12(a~~2.9(b)(iii) ~~License Agreement 3.16(a)(xi~~Loss 8.2(a) ~~License Agreements 3.16(a)(xi~~Losses 8.2(a) ~~Majority Effective Time Holders 9.1(c~~Material Contract 3.17(a) ~~Measurement Date 1.1~~ Material Contracts 3.17(a) Maximum Premium 6.16(c) Medicare Part D 3.23(i) Merger Recitals Merger Consideration 2.7(d) Merger Sub Preamble ~~Option Cancellation Agreement 2.13(c~~Merger Sub Preamble Objection Notice 8.4(b) ~~Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b~~Open Source Material 3.15(k) Out-~~of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b~~Licenses 3.15(e)(i) Parent Preamble Parent ~~Closing Balance Sheet 2.17(c~~Plans 6.9 Patents 1.1(hhh) ~~Parent~~ PCL 3.29(g) Personal Data 3.15(m)(i) Representatives ~~5.9 Parent Working Capital Determination 2.17(c~~5.3(a) ~~Parent Working Capital Statement 2.17(c~~Required Stockholder Approval Recitals Returns 3.12(b)(i) ~~Paying Agent 2.11(a~~RoHS Directive 1.1(oo) ~~Paying Agent Agreement 2.11(a~~SEC 4.8(a) ~~Payment Fund 2.11(a~~SEC Reports 4.8(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iiiSecurities Act 4.8(a) Specified Representations ~~10.2(a)(iii~~8.1(a) ~~▇▇▇▇▇ Law 3.12(b~~Spreadsheet 6.12 Statement of Expenses 6.11 Stockholder Representative Preamble Stockholder Representative Expenses 8.7(b) Stockholder ~~Approval 3.8~~ Written Consent Recitals Stockholder ~~Meeting 5.8(b~~Written Consents Preamble Surviving Corporation 2.1 Tax 3.12(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Taxes 3.12(a) ~~Survival Date 10.3(a~~Terminated Agreements 6.7(b) Termination Fees 6.7(b) Third Party Claim ~~10.4(b~~8.5 Third Party Expenses 6.11 Trademarks 1.1(hhh) ~~Working Capital Deficit 2.17(f~~Unresolved Claims 8.6(b) ~~Working Capital Objection Period 2.17(e~~URLs 1.1(hhh) ~~Working Capital Objection Statement 2.17(e~~User Data 3.15(m)(i) ~~Working Capital Surplus 2.17(f)~~WEEE Directive 1.1(oo) Year-End Financials 3.7

Appears in 1 contract

Sources: Merger Agreement (Actividentity Corp)

Appears in 1 contract

Sources: Merger Agreement (Secure Computing Corp)

Additional Defined Terms. ~~The~~ In addition to the terms defined in Section 1.1, each of the following terms ~~shall have~~ is defined in the ~~meanings~~ Section set forth ~~on the pages of this Agreement indicated below~~opposite such term: ~~280G Approval 6.3(c) 280G Payments 6.3(c)~~ Term Section Acquisition ~~Proposal 5.11 Acquisition Sub~~ Companies Preamble ~~Agreed Claims 10.4(g)~~ Agreement Preamble ~~Agreement Date~~ Alternative Transaction 7.5(c) Amended and Restated Community Loan 8.1(j)(i) Annual ERC Financials 5.6(a)(i) Annual ERC Sub Financials 5.6(b)(i) (i) Annual NSC-Supported NFP Financials 5.6(c)(i) Annual Standalone NFP Financials 5.6(b)(iii) (e) Ashburn Owner Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Ashburn Retained Cash 2.1(e) ~~Audited Balance Sheet 3.9(b~~Assumed Kansas Liabilities 2.3(a)(ii) ~~Audited Balance Sheet Date 3.9(b~~Assumed Liabilities 2.3 Assumed Management Liabilities 2.3(a)(ii) ~~Audited Financial Statements 3.9(b~~Assumed Subsidiary Liabilities 2.3(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Bankruptcy Case Recitals Bankruptcy Code Recitals Bankruptcy Court Recitals (a) Business Recitals Cash Collateral 2.1(c)(iii)(C) Claim Notice 10.3 Closing ~~2.4~~ 4.1 Closing Date ~~2.4~~ 4.1 Closing ~~Working Capital Estimate 2.17(a~~Cash Payment 3.2(b)(iv) ~~Company~~ Closing Date Cash Amount 3.2(b)(i) Commitment Fee 3.1 (f) Concord Owner Preamble ~~Company Board Approval 3.5 Company Certificate 2.10(e~~Concord Retained Cash 2.1(f) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Confidential Information 7.11 Construction Assets 2.1(l) ~~Company Preferred Stock 2.10(b~~Consulting and License Agreement 8.1(q)(ii) ~~Company Representative 5.11 Company Software 3.18(l~~Controlled Real Property 5.16(d) ~~Company Third Party Consents 6.3(b~~Covered Property and Operations 5.17(a)(i) ~~Company Warrant 2.14(a~~Credit Facilities 5.15(a)(v) (g) ~~Company Warrant Documents 2.12(a~~Dallas Owner Preamble Dallas Retained Cash 2.1(g) ~~Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~Determination Letter 5.11(a)(iii) ~~Delivered Tax Returns 3.22(a~~DevCo Preamble Development Contracts 5.15(a)(iv) ~~DGCL Preamble~~ DIP Financing 7.2(b)(i) Disclosure Statement ~~5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h~~7.1 Distributable Cash on Hand 3.2(b)(iii)(B) Employee ~~Plan 3.15(h~~Plans 5.20(a) ~~Employee Welfare Benefit Plan 3.15(h~~ERC Preamble ERC Assets 2.1(c)(iii) ~~Environmental Approvals 3.21(e~~ERC ▇▇▇▇ of Sale 4.2(a)(i)(G) ~~Environmental Reports 3.21(f~~ERC Conveyance Documents 4.2(a)(i)(G) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iiiERC Subs 5.1(b) ▇▇▇▇▇▇▇▇ ~~Law 3.12(b~~Agreements 5.2 ▇▇▇▇▇▇▇▇ Construction Preamble ▇▇▇▇▇▇▇▇ Disclosure Schedule Preamble to Article V ▇▇▇▇▇▇▇▇ Financials 5.6(b)(iv) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~▇▇▇▇▇▇▇▇ Indemnitees 10.2 ▇▇▇▇▇▇▇▇ Losses 10.2 ▇▇▇▇▇▇▇▇ Parties Preamble ERISA Affiliate 5.20(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Excluded Assets 2.2 Excluded Contracts 2.2(d) ~~Survival~~ Excluded Liabilities 2.4 Execution Date ~~10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Preamble FECA 5.11(f)

Appears in 1 contract

Sources: Master Purchase and Sale Agreement

Additional Defined Terms. The following additional terms ~~shall have the meanings~~ are set forth on and defined in the ~~pages~~ following respective Sections of ~~this Agreement indicated below~~the Agreement: ~~280G Approval 6.3(c~~2010 Balance Sheet 4.04(a)(ii) ~~280G Payments 6.3(c~~AAA 12.11(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Acquired Shares 2.01 Acquired Subsidiary Employees 6.05(a)(iii) after-Tax basis 10.02(c) Agreement Preamble ~~Agreement Date Preamble~~ Allocation ~~Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited~~ Schedule 7.02 Apportioned Obligations 7.04 Assumed Obligations 2.03 Balance Sheet Date ~~3.9(b~~4.04(a)(i) ~~Audited Financial Statements 3.9(b~~Basket 10.02 Bundled Software 4.13(a)(i)(A) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Business Recitals Business Assets 2.01(a) Business Employees 4.12(a)(i) Business Unit Recitals Buyer Preamble Buyer Affiliates 2.05 Buyer Fee 11.03(a) Buyer Indemnitees 10.02(a) Buyer Material Adverse Effect 5.04 Buyer Obligations 11.03(a) Buyer Warranty Breach 10.02(b)(i) Cap 10.03(a) CERCLA 1.01 Closing ~~2.4~~ 3.02(a) Closing Date ~~2.4~~ 3.02(a) Closing ~~Working Capital Estimate 2.17(a~~Statement 3.03(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Confidential Information 6.02(b) ~~Company~~ Connecticut Sublease 9.01(l) CPR 12.11(a) Customer List 2.01(b)(xii) Development Software 4.13(a)(i)(A) Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(aLetter Article IV Dispute Notice 3.03(c) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~3.02(d) ~~Employee Plan 3.15(h~~Excluded Assets 2.02 Excluded Contracts 4.08(e) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Excluded Liabilities 2.04 FICA 7.05 Financial Statements ~~3.9(b~~4.04 Financing 9.03 Fundamental Cap 10.03(a) ~~In-the-Money Company Option 2.13(a~~FUTA 7.05 GC Intellectual Property 2.02(b)(viii) ~~In-the-Money Company Warrant 2.14(a~~Guarantee 12.12(a) ~~Leased Property 3.14(a~~Guaranteed Obligations 12.12(a) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Hired Employees 6.05(a)(i) ~~License Agreement 3.16(a)(xi~~Independent Accountants 3.03(c) ~~License Agreements 3.16(a)(xi~~Lease Assignments 9.01(k) ~~Majority Effective Time Holders 9.1(c~~Leases 4.11(b) ~~Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c~~Marks 1.01 Material Contract 4.08(d) Material Schedule Update 6.07 Multiemployer Plan 4.12(b)(iv) Nonassignable Items 8.01(c) Organizational Documents ~~3.3 Out~~4.01 Party Preamble Parties Preamble PCBs 1.01 Post-~~of-the-Money Company Option 2.13(b~~Transition Employees 6.05(a)(i) ~~Out-of-the-Money Company Warrant 2.14(b~~Prepaids 2.01(b)(xix) ~~Outside Date 8.1(b~~Proceeding 4.06 Purchase Price 3.01 Qualified Plan 4.12(b)(v) ~~Parent Preamble Parent Closing Balance Sheet 2.17(c~~Real Property 4.11(a) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c~~Related Products and Services 6.03(a)(i) ~~Parent Working Capital Statement 2.17(c~~Required Contractual Consent 4.03 Required Legal Approval 4.03 Retained Employee 2.04(b) ~~Paying Agent 2.11(a~~Retained Names 2.02(l) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(aRetained Property 2.02(j) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Preamble Seller Indemnitees 10.02(b) ~~Specified Representations 10.2(a)(iii~~Seller Warranty Breach 10.02(a)(i) ~~▇▇▇▇▇ Law 3.12(b~~Service Agreements 4.11(d) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Seller Obligations 11.02(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Subordinated Notes 6.10 Tax Indemnitee 10.02(c) ~~Survival Date 10.3(a~~Temporarily Retained Employee 6.05(a) Termination Fee 11.02(a) Third Party Claim ~~10.4(b~~10.05 Trade Payables 2.03(e) ~~Working Capital Deficit 2.17(f~~Warranty Costs 4.16(b) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~WARN 6.05(d)

Appears in 1 contract

Sources: Asset Purchase Agreement (Gerber Scientific Inc)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Defined Terms Section Adjustment Amount 2.7(g) Agreement Preamble Amadeus Device Preamble Annual Sales Threshold 2.7(d) Anti-Bribery Laws 3.15(a) Assignment and Assumption Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.10(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇Assumed Liabilities 2.3 ▇▇▇▇ ~~Law 3.12(b~~of Sale 2.10(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Claim Notice 8.3(a) ~~Straddle~~ Closing 2.9 Closing Date 2.9 Closing Payment 2.5 Commercialization Payment 2.6(a) Commercialization Payment Date 2.6(a) Confidentiality Agreement 5.11(a) ConvaTec Preamble CTI Preamble Deductible 8.5(a) Defaulting Party 2.11 Equipment 2.1(c) Excluded Assets 2.2 Excluded Liabilities 2.4 FDA 3.11 FDCA 3.11(a) Financial Buyer 5.6(d) Included Contracts 2.1(b) Initial Sales Payment Period ~~1.1 Subsidiary Securities 3.2(b~~2.7(a) ~~Survival~~ Initial Sales Percentage Amount 2.7(a) Indemnified Party 8.3(a) Indemnifying Party 8.3(a) Independent Accounting Firm 2.7(f) Insurance Policy 5.8 Inventory 2.1(a) Large Acquisition 5.6(c) Non-Financial Buyer 5.6(d) Non-SMM Product Sales 2.7(a) Parent Preamble Patent Assignment 2.10(a) Payment Date ~~10.3(a~~2.14(a) Defined Terms Section Percentage Payments Determination Report 2.7(e) Percentage Payments Period 2.7(c) Permitted Acquisition 5.6(c) PPDR 2.7(e) Project Preamble Project Information 5.11(b) Purchase of a Restricted Business 5.6(c) Purchase Price 2.5 Purchased Assets 2.1 Purchased Intellectual Property 2.1(d) Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 8.1 Purchaser Information 5.4(e) Restricted Period 5.6(a) Relevant Acquisition 5.6(c) Sales Payment Period 2.7(c) Sales Percentage Amount 2.7(c) Seller Preamble Seller Disclosure Schedule Article 3 Seller Facility 2.12 Seller Indemnified Parties 8.2 Seller Information 5.4(d) Seller Marks 5.4(a) Seller Sale 5.6(d) Sellers Preamble SMM Platform Preamble SMM Product Sales 2.7(a) Software Assignment 2.10(a) Successor 5.9 Third Party Claim ~~10.4(b~~8.3(b) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Transfer Taxes 5.15

Appears in 1 contract

Sources: Asset Sale and Purchase Agreement

Additional Defined Terms. The following additional defined terms shall have the meanings set forth on in the ~~pages~~ sections of this Agreement ~~indicated~~ listed below: ~~280G Approval 6.3(c~~Alliance Functional Committees 3.02 Alliance Management 3.07 Alliance Strategic Committee 3.01 Alliance Strategic Decisions 3.01 Annual Budgetary Targets 4.01(a) ~~280G Payments 6.3(c~~BMS Preamble Breaching Party 7.06(iii) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Clopidogrel Recitals Clopidogrel License and Supply Agreement Recitals Clopidogrel Toll Manufacturing Agreement Recitals Concerned Party 7.05(b) Confidential Information 5.03(a) Co-Promotion Entity 4.01(a) Country Non-Terminating Party 7.03 Country Terminating Party 7.03 Covered Activities 6.02(a) Development Agreement ~~Preamble~~ Recitals Development Services Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Recitals Finance Committee 3.02 First Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a6.02(a) Indemnified ~~D&Os 6.4(a~~Party 6.03(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 6.03(a) ~~Interim Balance Sheet 3.9(b~~Indemnity Notice 6.03(d) ~~Interim Balance Sheet Date 3.9(b~~Independent Firm 7.08(a)(i) ~~Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a)~~ Irbesartan Recitals Irbesartan License Agreement ~~3.16(a)(xi~~Recitals Irbesartan Supply Agreement Recitals Irbesartan Toll Manufacturing Agreement Recitals Know-How License Agreement Recitals Long-Range Plans 4.01(a) ~~License Agreements 3.16(a)(xi~~SS_NYL2/171613 2 (PA_1/79522 2) ~~Majority Effective Time Holders 9.1(c~~* CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION Manufacturing and Sourcing Committee 3.02 Master Territory A Agreement Recitals Multiple 7.08(a) ~~Measurement Date 1.1 Merger~~ Non-Concerned Party 7.05(b)(ii) Non-Renewal Valuation 7.08(a) Notices 8.01 Partnership Services Agreement Recitals Party Preamble ~~Option Cancellation~~ Proposed Multiple 7.08(a)(i) Puerto Rico Purchase and Sale Agreement ~~2.13(c~~Recitals Réglement Intérieur Recitals Reporting Party 5.06(b) ~~Organizational Documents 3.3 Out~~Revised Projection 4.03 Safety Expert 7.05(b)(ii) Safety Problem 7.04(ii) Sanofi Preamble SNC By-~~of-the-Money Company Option 2.13(b~~Laws Recitals SNC Partnership Recitals Sterling Recitals Territory A Budget 4.01(a) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Territory Management Committee Recitals Third Party Claim ~~10.4(b~~6.03(a) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Toll Manufacturing Agreements Recitals Unsatisfactory Final Outcome 3.06(b)

Appears in 1 contract

Sources: Alliance Support Agreement (Bristol Myers Squibb Co)

Appears in 1 contract

Sources: Agreement and Plan of Merger and Reorganization (Supergen Inc)

Additional Defined Terms. ~~The~~ (i) For purposes of this Agreement and the other Acquisition Documents, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Acquisition Recitals Adjustment Amount 1.8(b) ~~280G Payments 6.3(c~~Adjustment Notice 1.9(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Aggregate Navy Payment Amount 1.6(a) Agreement Preamble ~~Agreement~~ Assets 1.1(c)(iii) Assignment and Novation Agreements 1.12(a)(viii) Assumed Contracts 1.1(b)(i) Assumed Contracts Liabilities 1.3(c) Assumed Liabilities 1.3 Assumed Tax Liabilities 1.3(d) Assumed WARN Act Liabilities 1.3(e) Basket 5.5(a) Beneficiary 1.13(b) Beneficial Rights 4.10(c) Benefit Programs 2.10(a) BHS Preamble ▇▇▇▇ of Sale 1.12(a)(ii) BSL Preamble Business Employee 4.6(a) Business Goodwill 1.1(c)(iii) Business Permits 4.10(a) Cash Consideration 1.5 Claim Notice 5.4(a) Closing 1.11 Closing Date 1.11 Dispute Notice 1.9(b)(ii) Disputed Items 1.9(d) EA Requests 4.11 Effective Date Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Employees 2.9(a) ~~Audited Balance Sheet 3.9(b~~Estimated Closing Adjustment 1.8(a) ~~Audited Balance Sheet Date 3.9(b~~Excluded Assets 1.2 Excluded Environmental Liabilities 1.4(j) ~~Audited Financial Statements 3.9(b~~Excluded IP 1.1(c)(i) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(aExcluded Liabilities 1.4 Facilitating Transfer 1.6(a) Final ~~Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~Purchase Price 1.9(h) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger 5.1 GI Preamble ~~Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent~~ GIFI Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement GIS Preamble ~~Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii~~GIS Assets 1.1(b) (a) ▇▇▇▇~~▇ Law 3.12(b~~▇▇▇▇/NC/TX IP 1.1(c)(i) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Indemnified Party 5.4(a) ~~Straddle~~ Indemnifying Party 5.4(a) Independent Accounting Firm 1.9(d) Independent Contractors 2.9(a) Intrusive Tests 5.5(d)(i) Lease Agreement 1.12(a)(vii) Lift Equipment 1.1(b)(iii) Navy Contract 1.1(b)(i) (a) Navy Overage Amount 1.6(b) OSU Contract 1.1(b)(i) Other Information 6.13(b) (a) Partial Navy Payment 1.6(a) Payee 1.13(b) Payor 1.13(b) Performance Bonds 1.12(b)(viii) Permitted Exceptions 4.7(b) Personal Property 1.1(b)(ii) Post-Closing Navy Payment 1.6(d) Post-Closing Purchased IP 4.14(a) Pre-Closing Collected Amount 1.6(c) Proration Items 1.13(a) Purchase Price 1.5 Purchased IP 1.1(c)(ii) Purchaser Indemnified Parties 5.2 Purchasers Preamble Purchasers’ Navy Payment Amount 1.6(b) Quitclaim Deed 1.12(a)(xi) Recipient 1.13(b) Restricted Area 4.7(d)(ii) Restricted Parties 4.3 Restricted Period ~~1.1 Subsidiary Securities 3.2(b~~4.7(d)(i) ~~Survival Date 10.3(a~~Secondment 4.6(e) ~~Third~~ Secondment Expenses 4.6(e) Secondment Period 4.6(e) Sellers Preamble Seller Construction Contracts 1.1(b)(i) Sellers’ Additional Navy Payment Amount 1.5 Shared Permits 4.10(b) Shared Permits Agreement 1.12(a)(ix) Shipyard Business Recitals Specified Excluded Contracts 1.2(a) Title Insurance Policy 4.13 Third-Party Claim ~~10.4(b~~5.4(a) ~~Working Capital Deficit 2.17(f~~Transfer Taxes 4.2 Transferability Impediments 1.1(c)(i) ~~Working Capital Objection Period 2.17(e~~TSA 1.12(a)(vi) ~~Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Vacation Expenses 4.6(b)

Appears in 1 contract

Sources: Asset Purchase Agreement (Gulf Island Fabrication Inc)

Additional Defined Terms. The following terms shall have the meanings set forth on in the ~~pages~~ sections of this Agreement indicated below: ~~280G Approval 6.3(c~~2007 Financials 4.9 2008 Financials 4.9 2009 Financials 4.9 2010 Financials 4.9 AVP Preamble AVR Plans 4.14(c) ~~280G Payments 6.3(c~~Claim 9.6 Claims 6.13 Claim Notice 9.6 Closing 2.3(a) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g) Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date ~~2.4~~ 2.3(a) Closing Payment 2.2(a) Company Preamble Continuing Employee 6.9 Deductible Amount 9.3 Disclosure Schedule Art. IV Effective Time 2.3(a) Estimated Closing Working Capital ~~Estimate 2.17(a~~3.1(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Estimated Excess Taxes 6.10(k) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Estimated Purchase Price 2.2(b) ~~Company Preferred Stock 2.10(b~~Exceptions Cap 9.4 Excess Tax Adjustment 6.10(l) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(bExcess Taxes 6.10(k) FDA ~~Requirements 3.19(a~~4.22(a) Final ~~Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~Allocation 6.10(j) Fundamental Representations ~~10.2(a)(ii~~9.1 General Cap 9.3 GLP 4.22(a) ~~HSR Act 6.2(a~~Government Contract 4.15(a) ~~Indemnified D&Os 6.4(a~~Historical Financial Statements 4.9 Latest Balance Sheet 4.9 Latest Financial Statements 4.9 Material Contracts 4.15(a) Non-Compete Period 6.12(b) Objection Notice 3.1(b) Party / Parties Preamble Payment Instructions Letter 2.2(b) Permits 4.22(d) Proceeding 6.10(e) Purchase Price 2.2(a) Purchaser Preamble Purchaser Benefit Plans 6.9 Purchaser Calculated Closing Working Capital 3.1(b) Purchaser Indemnified Parties ~~10.1(a~~9.2 Real Property Leases 4.13(a) ~~Interim Balance Sheet 3.9(b~~Related Persons 6.12(a) ~~Interim Balance Sheet Date 3.9(b~~Releasing Parties 6.13 Releasees 6.13 Section 338(h)(10) ~~Interim Financial Statements 3.9(b~~Election 6.10(i) ~~In-the-Money Company Option 2.13(a~~Section 6.10(i) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(aTax Liability 6.10(i) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Indemnified Parties 9.5 Shareholder Preamble Shares Recitals Territory 6.12(b) ~~Specified Representations 10.2(a)(iii~~Trade Secrets 6.12(a) ~~▇▇▇▇▇ Law 3.12(b~~Transaction 10.18 Transaction Expenses 8.1(a) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)Trust Preamble Trust Shares Recitals

Appears in 1 contract

Sources: Share Purchase Agreement (Akorn Inc)

Additional Defined Terms. ~~The~~ In addition to the terms defined in Section 1.1, each of the following terms ~~shall have~~ is defined in the ~~meanings~~ Section set forth ~~on the pages of this Agreement indicated below~~opposite such term: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Actual Earnings 2.3(c)(i) Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Annual Financials 4.6(a) ~~Audited Balance Sheet 3.9(b~~Annual Period 2.3(c)(ii) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iiiAudits 4.9(e) ▇▇▇▇▇ ~~Law 3.12(b~~Preamble Burdensome Condition 6.3 ▇▇▇▇▇▇▇ Preamble Buyer Preamble Buyer Agreements 5.2 Buyer Disclosure Schedules Preamble to Article V Buyer Indemnitees 8.1 Buyer Losses 8.1 Cap Amount 8.5(c)(iii) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Claim Notice 8.3 Claims Period 8.5(a) ~~Straddle~~ Closing 3.1 Closing Date 3.1 Closing Payment 2.2 Company Recitals Confidentiality 6.8 Cumulative Actual Earnings 2.3(c)(iii) Cumulative Targeted Earnings 2.3(c)(iv) Earn-out Period ~~1.1 Subsidiary~~ 2.3(c)(v) Execution Date Preamble Final Loss 8.4(e) Financial Statements 4.6(a) First Annual Period 2.3(c)(ii) First Preliminary Statement 2.4(a) Fourth Annual Period 2.3(c)(ii) HUD 4.19 Indemnified Party 8.3 Indemnifying Party 8.3 Leased Real Property 4.17(a)(i) Losses 8.5(d) Material Contracts 4.17(a) Measurement Date 2.3(c)(vi) ▇▇▇▇▇▇▇▇ Preamble Non-Competition, Non-Solicitation and Confidentiality Agreements 3.2(a)(i)(G) Outside Closing Date 9.1(b)(iii) Parties Preamble Personal Data 4.16(b) Pre-Closing Tax Period 8.1(c) Preliminary Statement 2.4(c) Premium Earn-Out Payment 2.3(c)(vii) Premium Earn-Out Payment Date 2.3(c)(viii) Real Property Leases 4.17(a)(i) Related Person 4.8 Representatives 6.6(a) Response Period 8.4(a) Second Annual Period 2.3(c)(ii) Securities ~~3.2(b~~Act 5.6 Seller Agreements 4.2 Seller Disclosure Schedules Preamble to Article IV Seller Indemnitees 8.2 Seller Losses 8.2 Sellers Preamble Shares Recitals Split-Dollar Arrangements 4.24(a) ~~Survival Date 10.3(a~~Targeted Earnings 2.3(c)(ix) Third Annual Period 2.3(c)(ii) Third Party ~~Claim 10.4(b~~Action 8.4(a) ~~Working Capital Deficit 2.17(f~~Third Party Action Notice 8.4(a) ~~Working Capital Objection Period 2.17(e~~Total Premium Earned 2.3(c)(x) ~~Working Capital Objection Statement 2.17(e~~Treasury Regulations 4.9(g) ~~Working Capital Surplus 2.17(f)~~True-Up Payment 2.3(c)(xi) Upfront Premium 2.3(c)(xii) Upfront Premium Allocation 2.3(c)(xiii) USA PATRIOT Act 4.15

Appears in 1 contract

Sources: Stock Purchase Agreement (HarborOne Bancorp, Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Amount 2.7(g) Agreement Preamble Amadeus Device Preamble Annual Sales Threshold 2.7(d) Anti-Bribery Laws 3.15(a) Assignment and Assumption Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.10(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇Assumed Liabilities 2.3 ▇▇▇▇ ~~Law 3.12(b~~of Sale 2.10(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Claim Notice 8.3(a) ~~Straddle~~ Closing 2.9 Closing Date 2.9 Closing Payment 2.5 Commercialization Payment 2.6(a) Commercialization Payment Date 2.6(a) Confidentiality Agreement 5.11(a) ConvaTec Preamble CTI Preamble Deductible 8.5(a) Defaulting Party 2.11 Equipment 2.1(c) Excluded Assets 2.2 Excluded Liabilities 2.4 FDA 3.11 FDCA 3.11(a) Financial Buyer 5.6(d) Included Contracts 2.1(b) Initial Sales Payment Period ~~1.1 Subsidiary Securities 3.2(b~~2.7(a) ~~Survival~~ Initial Sales Percentage Amount 2.7(a) Indemnified Party 8.3(a) Indemnifying Party 8.3(a) Independent Accounting Firm 2.7(f) Insurance Policy 5.8 Inventory 2.1(a) Large Acquisition 5.6(c) Non-Financial Buyer 5.6(d) Non-SMM Product Sales 2.7(a) Parent Preamble Patent Assignment 2.10(a) Payment Date ~~10.3(a~~2.14(a) Percentage Payments Determination Report 2.7(e) Percentage Payments Period 2.7(c) Permitted Acquisition 5.6(c) PPDR 2.7(e) Project Preamble Project Information 5.11(b) Purchase of a Restricted Business 5.6(c) Purchase Price 2.5 Purchased Assets 2.1 Purchased Intellectual Property 2.1(d) Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 8.1 Purchaser Information 5.4(e) Restricted Period 5.6(a) Relevant Acquisition 5.6(c) Sales Payment Period 2.7(c) Sales Percentage Amount 2.7(c) Seller Preamble Seller Disclosure Schedule Article 3 Seller Facility 2.12 Seller Indemnified Parties 8.2 Seller Information 5.4(d) Seller Marks 5.4(a) Seller Sale 5.6(d) Sellers Preamble SMM Platform Preamble SMM Product Sales 2.7(a) Software Assignment 2.10(a) Successor 5.9 Third Party Claim ~~10.4(b~~8.3(b) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Transfer Taxes 5.15

Appears in 1 contract

Sources: Asset Sale and Purchase Agreement (Tactile Systems Technology Inc)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: 280G ~~Approval 6.3(c~~Waiver Recitals 401(k) ~~280G Payments 6.3(c~~Plan 7.13 Accountant 2.10(e)(ii) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Affiliates Legend 2.16(b) Agent Indemnification Expenses 9.7(d)(vii) Agent Interpleader Expenses 9.7(d)(vi) Agreement Preamble ~~Agreement~~ Alternate Transaction 6.4(a) Applicable Expiration Date ~~Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~9.1(a) ~~Audited Balance Sheet 3.9(b~~Appraiser 2.10(e)(ii) ~~Audited~~ Balance Sheet Date ~~3.9(b~~3.7 California Permit 7.12 Certificate of Incorporation 3.1(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8~~ Certificate of Merger ~~2.4 Claims 10.4 CLIA 1.1~~ 2.3 Charter Documents 3.1(a) Claim Certificate 9.5(a) Closing ~~2.4~~ 2.2 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a)~~ 2.2 Company Preamble Company ~~Board Approval~~ Authorizations 3.21 Company Stock Certificates 2.9(b)(iii) Conflict 3.5 ~~Company Certificate 2.10(e~~Consents 3.6 Current Balance Sheet 3.7 Customer Information 3.14(f) ~~Company~~ Deferred Merger Consideration 2.10(a)(ii)(2) Deferred Merger Consideration Notice 2.10(e)(i) Delaware Law 2.1 Director and Officer Resignation Letter 7.8(b) Disclosure Schedule ~~3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Article III Dispute Notice 2.10(e)(i) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(aDissenting Share Payments 2.8(c) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~2.8(a) Domain Names 1.1(bbb) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~2.3 Escrow Expenses 9.7(e) Escrow ~~Agent 2.16~~ Fund 9.7(a) Escrow ~~Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b~~Period 9.7(b) ~~FDA Requirements 3.19(a~~Excess Third Party Expenses 7.14 Exchange Documents 2.9(b)(iii) ~~Final Working Capital 2.17(e~~Expiration Date 9.1(a) ~~Firm 11.9 FTC 6.2(a~~FCPA 3.29 Financials 3.7 FIRPTA Compliance Certificate 7.17 First Milestone Amount 2.10(a)(i)(1) ~~Fundamental Representations 10.2(a)(ii~~Form S-3 Registration Statement 7.11(c) ~~HSR Act 6.2(a~~Governmental Entity 3.6 Health Care Laws 3.18 Indemnified Parties 9.2(a) Indemnified ~~D&Os 6.4(a~~Party 9.2(a) ~~Indemnified Parties 10.1(a~~Information Statement 7.1(a) Intellectual Property Contracts 1(a)(iii) Interim ~~Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~Financials 3.7 Key Employee Offer Letters Recitals Lease Agreements 3.14(b) Leased Real Property 3.14(a) Letter ~~Amendment Premable Letter~~ of Transmittal ~~2.12(a~~2.9(b)(i) ~~License Agreement 3.16(a)(xi~~Loss 9.2(a) ~~License~~ Losses 9.2(a) Material Contract 3.17(a) Material Contracts 3.17(a) Merger Recitals Milestone Payment Date 2.10(a)(i) Non-Competition Agreements ~~3.16(a)(xi~~Recitals Objection Notice 9.5(b) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(bOffer Letter 7.9(a) Parent Preamble Parent ~~Closing~~ 10-K 4.6 Parent Balance Sheet ~~2.17(c~~5.6(b) Parent ~~Representatives 5.9 Parent Working Capital Determination 2.17(c~~Financials 5.6(b) Parent ~~Working Capital Statement 2.17(c~~Preferred Stock 5.5(a) ~~Paying Agent 2.11(a~~Parent SEC Reports 5.6(a) ~~Paying Agent Agreement 2.11(a~~Parent Stock Plans 5.5(a) ~~Payment Fund 2.11(a~~Patents 1.1(bbb) ~~Pre-Closing~~ Permit Application 7.12 Principal Stockholder Preamble Principal Stockholders Preamble Required Stockholder Approval Recitals Returns 3.12(b)(i) Right of Setoff 2.10(g) RoHS Directive 1.1(jj) Second Milestone Amount 2.10(a)(ii)(1) Second Milestone Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iiiIncremental Sales 2.10(a)(ii)(1) Specified Representations ~~10.2(a)(iii~~9.1(a) ~~▇▇▇▇▇ Law 3.12(b~~Spreadsheet 7.15 Statement of Expenses 7.14 Stockholder Certificate 7.11(a) Stockholder ~~Approval 3.8~~ Written Consent Recitals Stockholder ~~Meeting 5.8(b~~Written Consents Recitals Superior Transaction 6.4(d) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Surviving Corporation 2.1 Tax 3.12(a) ~~Survival Date 10.3(a~~Taxes 3.12(a) Terminated Agreements 7.7(b) Third Party Claim ~~10.4(b~~9.6(a) ~~Working Capital Deficit 2.17(f~~Third Party Expenses 7.14 Trademarks 1.1(bbb) ~~Working Capital Objection Period 2.17(e~~Unresolved Claims 9.7(b) ~~Working Capital Objection Statement 2.17(e~~URLs 1.1(bbb) ~~Working Capital Surplus 2.17(f)~~WEEE Directive 1.1(jj) Year-End Financials 3.7

Appears in 1 contract

Sources: Merger Agreement (Foxhollow Technologies, Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Accounting Principles 3.10(b) ~~280G Payments 6.3(c~~Accounts Payable 2.1(c) (a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Acquired Intellectual Property 2.1(a)(iv) Additional Asset 2.8(b) Agreement Preamble Agreement Date Preamble Allocation ~~Certificate 6.8 Antitrust Filings 6.2(a~~Statement 2.7(a) ~~Audited~~ Ancillary Agreements 3.1 Assignment of Intellectual Property 2.6(e) Assumed Contracts 2.1(a)(v) Assumed Liabilities 2.1(c)(i) (b) Balance Sheet ~~3.9(b~~3.10 (a) ~~Audited~~ Balance Sheet Date ~~3.9(b~~3.10(a) ~~Audited Financial Statements 3.9(b~~▇▇▇▇ of Sale 2.6(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4~~ Business Recitals Business Employees 3.11 Claim 8.5(a) Claims ~~10.4 CLIA 1.1~~ Period 8.5(b) Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Net AR 2.3 Closing Net Inventory Value 2.3 Closing Payment 2.2 Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~5.12(a) ~~Delivered Tax Returns 3.22(a~~Contested Claim 8.8(b) ~~DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h~~Contributor 3.8(d) Employee ~~Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h~~Liabilities 5.9(b) Environmental ~~Approvals 3.21(e) Environmental Reports 3.21(f~~and Safety laws 3.13(a)(i) Escrow Agent ~~2.16~~ 2.5 Escrow Agreement ~~2.16~~ 2.5 Escrow Cash 2.5 Escrow Fund ~~2.16 Estimated Working Capital Surplus 2.17(b~~8.1 Equipment 2.1(a)(iii) ~~FDA Requirements 3.19(a~~Excluded Liabilities 2.1(c)(ii) ~~Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~Facilities 3.13(a)(iii) (a) Fundamental Representations ~~10.2(a)(ii~~8.2 Hazardous Materials 3.14(a)(ii) ~~HSR Act 6.2(a~~Indemnifiable Damages 8.3 Indemnified Person 8.3 Indemnified Persons 8.3 Insurance Policy 3.19 Material Contracts 3.16 Miltope Name 5.15(a) ~~Indemnified D&Os 6.4(a~~Miltope Name Period 5.15(a) ~~Indemnified Parties 10.1(a~~Negative Adjustment 2.3(a) ~~Interim Balance Sheet 3.9(b~~Negative Adjustment Threshold 2.3(a) ~~Interim Balance Sheet Date 3.9(b~~Non-Solicitation Period 5.6 Notice of Claim 8.5(a) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(bOpen Source Materials 3.8(i) Outside Date ~~8.1(b~~7.1 Party Preamble Patent Assignment 2.6(f) ~~Parent~~ Positive Adjustment 2.3(a) Property 3.13(a)(iv) Purchase Price 2.2 Purchase Price Adjustment 2.3(a) Purchaser Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Restricted Area 5.5 Restricted Business 5.5 Restricted Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement~~ 5.5 Seller Preamble ~~Related Agreements 3.5(a~~Seller Authorizations 3.4(b) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Disclosure Letter Article III Straddle Periods 5.10(b) ~~Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third~~ Purchaser Disclosure Letter Article IV Third-Party Claim ~~10.4(b~~8.5(a)(ii) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Transaction Recitals Transaction Taxes 5.10(a)

Appears in 1 contract

Sources: Asset Purchase Agreement (Astro Med Inc /New/)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Agreement Preamble ~~Agreement Date~~ Assumed Accounts Payable 1.5(a) Asset Purchase Recitals Assumed Liabilities 1.5(a) Assumed Warranty Claims 1.5(a) Basket Amount 7.2(b) ▇▇▇▇ of Sale 1.7(c)(2) Business Authorizations 2.17 Buyer Parent Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Buyer Party(ies) ~~Audited Balance Sheet 3.9(b~~Preamble Buyer Preamble Cash Amount 1.7(a) ~~Audited Balance Sheet Date 3.9(b~~Cap 7.3(c) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Charter Documents 2.1 Closing ~~2.4~~ 1.6 Closing Date 1.6 Confidentiality Agreement 5.2 Conflict 2.4 ~~Closing Working Capital Estimate 2.17(a~~Consultant Proprietary Information Agreement 2.9(q) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Contract(s) ~~Company~~ 2.4 Counsel 5.1(c) Disclosure Schedule ~~3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Article II Escrow Agreement 7.3(a) ~~Company Preferred Stock 2.10(b~~Escrow Amount 7.3(a) ~~Company Representative 5.11 Company Software 3.18(l~~Escrow Fund 7.3(a) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(hEscrow Period 7.3(b) Employee ~~Plan 3.15(h~~Proprietary Information Agreement 2.9(q) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(aExcluded Assets 1.4 GAAP 2.11 Inbound-Licenses 2.9(j) Indemnified Parties ~~10.1(a~~7.2(a) ~~Interim Balance Sheet 3.9(b~~Indemnifying Parties 7.2(a) ~~Interim Balance Sheet Date 3.9(b~~IP Contracts 2.9(k) ~~Interim Financial Statements 3.9(b~~IP Recordation Agreements 1.7(c)(ii) ~~In-the-Money Company Option 2.13(a~~Key Employee Employment Agreement 1.5(c) ~~In-the-Money Company Warrant 2.14(a~~Lease Agreements 2.8(a) Leased Real Property ~~3.14(a~~2.8(a) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Loss(es) 7.2(a) Material Contracts 2.10(a) Malware 2.9(w) Non-Assignable Asset 5.1(e) Non-Paying Party 5.5(b)(iii) Objection Notice 7.4(a) Officer’s Certificate 7.4(a) Open Source License ~~Agreement 3.16(a)(xi~~1.1 Other Tax Controversy 7.4(c) ~~License Agreements 3.16(a)(xi~~Outbound-Licenses 2.9(j) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(bPaying Party 5.5(b)(iii) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(aPlan 5.7(e) Pre-Closing ~~Period 6.1 Preliminary Closing Balance Sheet 2.17(a~~Tax Controversy 7.4(c) ~~Preliminary Closing Statement 2.17(a~~Projections 2.11 Purchase Price 1.7(a) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Purchased Assets 1.3(h) Regular Quarterly Financial Information 2.11 Retained Liabilities 1.5(b) Returns 2.6(b) Seller ~~Group 11.19 Series D Stock 1.1~~ Preamble Seller Parties Preamble Seller Secretary Certificate 6.2(f) Seller Sub Preamble Special Representations ~~10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b)~~ 7.1 Straddle Period ~~1.1 Subsidiary Securities 3.2(b~~Tax 5.5(b)(iii) Survival Date ~~10.3(a~~7.1 Tax(es) 2.6(a) Third Party Claim ~~10.4(b~~7.4(b) ~~Working Capital Deficit 2.17(f~~Third Party Expenses 5.3 Transferred Employees 5.7(a) ~~Working Capital Objection Period 2.17(e~~Transfer Taxes 5.5(a) ~~Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~WARN 2.21(e)

Appears in 1 contract

Sources: Asset Purchase Agreement (Rambus Inc)

Additional Defined Terms. The following ~~terms~~ additional terms, wherever used in this Agreement, shall have the respective meanings ~~set forth on~~ specified in the ~~pages~~ Sections of this Agreement ~~indicated below~~set forth below after such terms: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ ADA Remedial Work 13.13 Adjustment Point 6.1 Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited~~ Allocated Purchase Price 3.2 Anchorage Joint Venture 7.1.21 Applicable Period 33.4 Appurtenances 2.1.2 Asset Allocations 3.2 Balance ~~Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ 3.1.3 Bankruptcy Code 3.1.2 Basket 8.9.2 Broker 15.1 Cash 2.2.2 Casualty Loss 12.1.1 Closing Date ~~2.4~~ 5.1 Closing ~~Working Capital Estimate 2.17(a) Company~~ Deposit 5.1 Collective Bargaining Agreements 8.3.13 Deed 7.1.1 Deposit 3.1.1 ERISA 33.4 Excluded Items 2.2 Fund 33.4 Guest Property 6.3 Hotel Recitals Hotels Recitals Incremental ADA Costs 13.13 Indemnifying Party 34 Initial Closing Date 5.1 Interstate 8.3.13 Land 2.1.1 Leasing Costs 6.4.1 Ledger 6.1.12 MHOP 10.5 MHOP ROFO 10.5 Monetary Liens 14.1 Multiemployer Plan 33.4 OFAC 35 Operating Lessee Preamble ~~Company Board Approval 3.5 Company~~ Other Franchisor 13.7.1 Partial Termination Procedure 12.1.2 PBGC 33.4 Permitted Exceptions 4 PIP Default Risk 6.5.2 Properties 2.1 Property 2.1 Proprietary Materials 2.2.6 Protected Party 34 Purchase Price 3.1 Purchaser Preamble Purchaser’s Leasing Costs 6.4.2 Purchaser’s Representation Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL 7.2.4 Release 10.4 Repair Contract 6.5.3 Repair Contractor 6.5.3 Repair Proposal 6.5.3 Seller Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Seller’s knowledge 8.4 Seller’s possession 8.4 Seller’s Representation Certificate 7.1.12 Sellers Preamble Title Affidavit 7.1.13 Trademark Materials 2.2.1 Transfer Taxes 17.1 Transferred Employees 33.1 WARN Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)33.2

Appears in 1 contract

Sources: Contract of Sale (Ashford Hospitality Trust Inc)

Appears in 1 contract

Sources: Stockholders’ Agreement (F45 Training Holdings Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Acquisition and Disposition Fee Shortfall 3.4(a)(i) ~~280G Payments 6.3(c~~Actual Closing Balance Sheets 3.2(b) ~~Acquisition Proposal 5.11 Acquisition Sub~~ Actual Closing Date Cash 3.2(b) Actual Closing Date Unpaid Indebtedness 3.2(b) Actual Closing Date Unpaid Transaction Expenses 3.2(b) Actual Closing Date Working Capital 3.2(b) Additional Indemnitor Preamble Additional Indemnitors Preamble Agreed ~~Claims 10.4(g~~Adjustments 3.2(d) Agreement Preamble ~~Agreement~~ AHI Preamble AHI Disclosure Letter 5 AHI Principals Preamble Assumed Liabilities 2.1(d) Basket 11.4(a) Business Intellectual Property 5.15(a) Cap 11.4(a) Change of Recommendation 8.9 Claim 11.5(a) Closing 4.1 Closing Contribution 3.1 Closing Date 4.1 Colony Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Consolidated Entities 5.11(a) ~~Audited Balance Sheet 3.9(b~~Contributed Assets 2.1(b) ~~Audited Balance Sheet~~ Covered Persons 8.11(c) Current Fee Participation Amount 3.4(a)(ii) Current Fee Participation Payment 3.4(a)(iii) Data Room 12.1(a) Dispute Period 3.4(f) DLA 12.1(a) Earnout Clawback 3.4(b) Earnout Consideration 3.4(b) Earnout Consideration Statement 3.4(e) Earnout Period 3.4(a)(iv) Estimated Closing Date ~~3.9(b~~Cash 3.2(a) ~~Audited~~ Estimated Closing Date Unpaid Indebtedness 3.2(a) Estimated Closing Date Unpaid Transaction Expenses 3.2(a) Estimated Closing Date Working Capital 3.2(a) Estimated Closing Statement 3.2(a) Final Adjustment Amount 3.2(e) Final Closing Date Value 3.2(e) Financial Statements ~~3.9(b~~5.11(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing~~ First Minimum Funding Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii3.4(c) ▇▇▇▇▇▇▇▇ ~~Law 3.12(b~~Trust Preamble FLSA 5.10(j) Fund Carried Interest 3.4(a)(v) Fund Costs 3.4(a)(vi) Fund Management Fees 3.4(a)(vii) Fund Placement Fees 3.4(a)(viii) Fund Transaction Fee Adjustment 3.4(a)(ix) Fundamental Representations 11.1 ▇▇▇▇ III Preamble ▇▇▇▇ III Board Recitals ▇▇▇▇ III Capital Contributions 3.4(a)(x) ▇▇▇▇ III Common Stock 7.5(a) ▇▇▇▇ III Indemnified Persons 11.3 ▇▇▇▇ III OP Preamble ▇▇▇▇ III Preferred Stock 7.5(a) ▇▇▇▇ IV Recitals ▇▇▇▇ IV OP Recitals ▇▇▇▇ Plans 8.15(b) Government Entity 5.20(b) GP Claw-Back 3.4(a)(xi) GP Indemnification Costs 3.4(a)(xii) ▇▇▇▇▇▇▇ Capital Preamble HoldCo Recitals HoldCo to NewCo Pre-Closing Contributions 2.1(b) Imputed Fee Generation Amount 3.4(a)(xiii) Independent Directors 3.4(e) Leased Real Property 5.16(a) Material Contracts 5.13(a) Merger Agreement Recitals Merger Exchange Ratio Recitals Merger Sub Recitals NewCo Recitals NewCo Interests Recitals Notice of Disagreement 3.4(f) Objection 3.2(d) Objection Notice 3.2(c) OP Merger Recitals Offer Employee 8.15(a) Offer Letter 8.15(a) Personal Information 5.22 Post-Closing Statement 3.2(b) Post-Merger OP Operating Agreement Recitals Pre-Merger OP Operating Agreement Recitals Proxy Statement 8.8(a) Real Property Leases 5.16(a) Recommendation 7.2(b) REIT Merger Recitals Requisite ▇▇▇▇ III Stockholder Approval ~~3.8 Stockholder Meeting 5.8(b~~7.2(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Retained Assets 2.1(c) ~~Survival Date 10.3(a~~Retained Liabilities 2.1(e) Special Committee Recitals Sponsor Preamble Sponsor Indemnified Persons 11.2 Sponsor Indemnifying Parties 11.3 Sponsor Representative Agreement 12.4(b) Sponsor to HoldCo Pre-Closing Contributions 2.1(a) Sponsors Preamble Third Party Claim ~~10.4(b~~11.6(a) ~~Working~~ Total Consideration 3.1 Transferred Books and Records 2.1(b)(iv) Unreturned ▇▇▇▇ III Capital ~~Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Contributions 3.4(a)(xiv)

Appears in 1 contract

Sources: Contribution Agreement (Griffin-American Healthcare REIT III, Inc.)

Additional Defined Terms. The following terms ~~shall have~~ are defined elsewhere in this Agreement in the ~~meanings set forth~~ Sections and on the pages ~~of this Agreement indicated below~~indicated: 280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g) Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA Act 1.13 3 Affiliate 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company 2 Class A Common Stock Recitations 1 Class B Common Stock Recitations 1 Class A Preferred Stock ~~2.10(b~~Recitations 2 Class B Preferred Stock Recitations 1 Commission 4.2(a) 22 Common Stock 1.6 2 Company ~~Representative 5.11 Company Software 3.18(l~~Introduction 8 Control 1.7 2 Controlled by 1.7 2 Demanding Holders 4.2(a) ~~Company Third Party Consents 6.3(b~~22 Demand Notice 4.2(a) ~~Company Warrant 2.14(a~~22 Demand Registration Period 4.3(a) ~~Company Warrant Documents 2.12(a~~23 Demand Registration Statement 4.2(a) ~~Confidentiality~~ 22 Demand Securities 4.2(a) 22 Derivative Securities 1.8 2 Exchange Act 4.3(d) 27 Existing Stockholders’ Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) Recitations 1 ▇▇▇▇▇▇▇▇ ~~Law 3.12(b~~Introduction 1 ▇▇▇▇▇▇▇▇ Class B Preferred Shares Recitations 1 ▇▇▇▇▇▇▇▇ Common Shares Recitations 1 ▇▇▇▇▇▇▇▇ Securities 1.29 4 ▇▇▇▇▇▇▇▇ Shares Recitations 1 Holdings Introduction 1 in Control of 1.7 2 Indemnified Parties 4.3(d) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~27 Indemnifying Party 4.3(f) ~~Straddle Period 1.1 Subsidiary~~ 28 Initial Parties Introduction 1 Initial Party Introduction 1 Initial Public Offering 1.13 3 Permitted Transferee 1.23 4 Person 1.24 4 Piggyback Shares 4.1 21 Registered Securities ~~3.2(b~~4.3(c)(ii)(D) ~~Survival Date 10.3(a)~~ 24 Registering Parties 4.1 21 Registration Statement 4.1 21 Securities Recitations 4 Shares Recitations 1 Third Party ~~Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Securities 4.1 21 under common Control with 1.7 2 Underwriter’s Cutback 4.1 21 Warrants Recitations 1 Whitney Introduction 1 Whitney Class B Preferred Shares Recitations 1 Whitney Common Shares Recitations 1 Whitney Investor Introduction 1 Whitney Management 1.33 5 Whitney Parties 1.35 5 Whitney Securities 1.29 4 Whitney V Recitations 1

Appears in 1 contract

Sources: Stockholders’ Agreement (RBC Bearings INC)

Additional Defined Terms. ~~The~~ Each of the following terms ~~shall have~~ is defined in the ~~meanings~~ Section set forth ~~on the pages of this Agreement indicated below~~opposite such term: ~~280G Approval 6.3(c) 280G Payments 6.3(c)~~ Acquisition Proposal ~~5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ 7.1 Affiliated Persons 4.22 Adjusted Purchase Price 2.2 Agreement Preamble ~~Agreement~~ Antitrust Laws 7.3(b) Antitrust Order 7.3(b) Canadian Subsidiary 8.2(d) Cap 11.3(b) Cash Shortfall 2.4(g) Closing 2.3 Closing Date ~~Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited~~ 2.3 Closing Date Balance Sheet ~~3.9(b~~2.4(c) ~~Audited~~ Closing Date Statement 2.4(c) Company Employee Plans 4.14(a) Company Indemnified Parties 7.5(a) Company Intellectual Property 4.13(b) Company Leases 4.10(b) Company Material Contracts 4.16(a) Company Permits 4.21 Confidentiality Agreement 6.2 Continuing Employees 7.7 Disclosure Supplement 13.7 Dispute 11.2(a) Employee Benefit Plan 4.14(a) Environmental Law 4.12(b) ERISA 4.14(a) ERISA Affiliate 4.14(a) Escrow Amount 2.2 Estimated Closing Date Balance Sheet ~~Date 3.9(b~~2.4(a) ~~Audited Financial Statements 3.9(b~~Estimated Excess Cash 2.4(a) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital ~~Surplus 2.17(b~~2.4(a) ~~FDA Requirements 3.19(a~~Excess Cash 2.4(g) ~~Final~~ Excess Working Capital ~~2.17(e~~2.4(h) Expiration Date 11.3(a) Financial Statements 4.6(a) Firm ~~11.9 FTC 6.2(a~~13.14 Hazardous Substance 4.12(c) ~~Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Healthcare Reform Law 4.14(l) Indemnified ~~D&Os 6.4(a~~Person 11.2(a) ~~Indemnified Parties 10.1(a~~Indemnifying Person 11.2(b) ~~Interim~~ Initial Closing Date Certificate 2.4(a) Intellectual Property 4.13(a) IRS 4.14(b) IP Contracts License Agreement 4.13(h) 4.13(d) Members’ Representative 13.13(a) Most Recent Balance Sheet ~~3.9(b~~4.6(a) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter~~ Notice of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(bClaim 11.2(a) Outside Date ~~8.1(b~~9.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Parties Preamble Party Preamble Pre-Closing Period 6.1 ~~Preliminary Closing Balance Sheet 2.17(a~~Pro Rata Share 11.1(a) ~~Preliminary Closing Statement 2.17(a~~Proprietary Information 13.1(a) ~~Prior Merger Agreement~~ Purchase Price 2.2 Purchaser Preamble ~~Related Agreements 3.5(a~~Purchaser Disclosure Schedule Article V Purchaser Employee Plan 7.7 Purchaser Indemnified Persons 11.1(a) Purchaser Indemnification Claim 11.1(a) Requisite Member 13.13(d) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Indemnified Persons 11.1(b) ~~Specified Representations 10.2(a)(iii~~Seller Indemnification Claim 11.1(b) ~~▇▇▇▇▇ Law 3.12(b~~Seller Objections 2.4(e) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1~~ Seller Preamble Subsidiary ~~Securities 3.2(b) Survival Date 10.3(a~~4.5(a) Third Party Claim ~~10.4(b~~11.2(b) Third Party Intellectual Property 4.13(h) Third Party Notice 11.2(b) Top Merchants 4.23(a) Top Referral Partners 4.23(a) Top Vendors 4.23(a) Transaction Preamble Working Capital ~~Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Shortfall 2.4(h)

Appears in 1 contract

Sources: Membership Interest Purchase Agreement (Vantiv, Inc.)

Additional Defined Terms. The following terms ~~shall~~ have the meanings ~~set forth on~~ ascribed to them in the ~~pages of this Agreement indicated~~ applicable sections referenced below~~: 280G Approval 6.3(c) 280G Payments 6.3(c)~~ . Acquisition ~~Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Amount 2.1 Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Arbitration Demand 8.7(b) ~~Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8~~ Certificate of Merger ~~2.4 Claims 10.4 CLIA 1.1~~ 1.3 Closing ~~2.4~~ 1.2 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a)~~ 1.2 Common Stock Recitals Company Preamble Company ~~Board Approval 3.5 Company Certificate 2.10(e~~Contracts 3.12(a) Company ~~Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Regulatory Agency 3.28(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval ~~3.8~~ Recitals D&O ~~Cap 6.4(b) Delivered Tax Returns 3.22(a~~Indemnified Parties 5.5(a) DGCL ~~Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~1.1 Dispute Notice 8.7(a) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~1.3 Enforceability Exceptions 3.2(b) Escrow ~~Agent 2.16~~ Period 7.5(d) FCPA 3.25 FDA 3.28(a) Financial Statements 3.7 Fully-Diluted Shares Recitals Indebtedness Pay-off Amount 2.1 Indemnification Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(aTermination Date 2.3(a)(ii) Indemnified ~~D&Os 6.4(a~~Party 7.3(a) ~~Indemnified~~ Indemnifying Party 7.3(a) Insured Parties ~~10.1(a~~5.5(b) ~~Interim~~ Major Customers 3.23(a) Major Suppliers 3.23(a) Merger Recitals Merger Consideration 2.1 Merger Sub Preamble Most Recent Balance Sheet ~~3.9(b~~3.7 Option Holder Recitals Option Merger Consideration Payable at Closing 2.1(f) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Outstanding Shares Recitals Parent Preamble Parent ~~Closing Balance Sheet 2.17(c~~Basket 7.4(a) Parent ~~Representatives 5.9 Parent Working Capital Determination 2.17(c~~De Minimis Threshold 7.4(a) Parent ~~Working Capital Statement 2.17(c~~Indemnified Parties 7.1(a) ~~Paying Agent 2.11(a~~Parent Losses 7.1(b) ~~Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre~~Parties Preamble Party Preamble Per-~~Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior~~ Option Merger ~~Agreement Preamble Related Agreements~~ Consideration 2.1 Per-Share Merger Consideration 2.1 Preferred Stock Recitals Real Estate Leases 3.5(a) ~~Seller Group 11.19 Series D Stock 1.1~~ Release Agreement 2.3(b) Share Merger Consideration Payable at Closing 2.1(e) Special ~~Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b~~Financial Statements 6.5 Stockholder Recitals Stockholder Indemnified Parties 7.2(a) Stockholder ~~Approval 3.8~~ Losses 7.2(b) Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)Notice 5.4 Stockholder Representative Preamble Surviving Company 1.1

Appears in 1 contract

Sources: Merger Agreement (Medical Action Industries Inc)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: Capitalized Term Section 280G Approval ~~6.3(c)~~ 6.9 280G ~~Payments 6.3(c~~Waiver 7.2(g) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~401(k) Plan 6.12(a) Action of Divestiture 6.6 Actual Closing Net Working Capital 2.9(c)(iii) Actual Closing Net Working Capital Statement 2.9(c)(i) Agent Indemnification Expenses 8.7(f)(vii) Agent Interpleader Expenses 8.7(f)(vi) Agreement Preamble Agreement Date Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Agreement of Merger 2.3(a) Agreements of Mergers 2.3(b) Anticorruption Laws 3.21(c) Assumed Options 2.7(f)(i) Audited ~~Balance Sheet 3.9(b~~Financials 3.6(a) ~~Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b~~Base Merger Consideration 2.9(a)(i) California ~~Stockholder Approval 3.8~~ Commissioner 6.1(a) California Permit 6.1(a) Cancellation Notices 6.7 CCC Recitals Certificates 8.1(a) Change of Control Fees 6.7 Capitalized Term Section Charter Amendment 6.25 Claim Certificate ~~of Merger 2.4 Claims 10.4 CLIA 1.1~~ 8.5(a) Claim Date 8.5(a) Closing ~~2.4~~ 2.2 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a)~~ 2.2 Communications Plan 6.5 Company Preamble Company ~~Board Approval 3.5 Company Certificate 2.10(e~~Auditors 3.6(a) Company Authorizations 3.15(a) Company Copyrights 3.11(a)(i) Company Indemnitees 6.23(a) Company Intellectual Property Assets 3.11(a)(ii) Company Marks 3.11(a)(iii) Company Patents 3.11(a)(iv) Company Privacy Policy 3.11(a)(v) Company Registered IP 3.11(a)(vi) Company Representatives 5.3(a) Company Shareholders’ Meeting 6.1(h) Company Stock Certificates 2.10(c)(ii) Company Trade Secrets 3.11(a)(vii) Company Treasury Stock 2.7(b) Compensation Schedule 3.19(a) Conflict 3.4(a) Consent and Modification Fees 6.7 Convertible Notes 5.2(f) Copyrights 3.11(a)(x) Credit Line Advance Amount 6.22 Current Balance Sheet 3.6(a) Customer Information 3.11(a)(ix) Designated Securityholder Recitals Director and Officer Resignation Letter 6.10(b) Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(aArticle III Dissenting Share Payments 2.8(c) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~2.8(a) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~2.3 Election Notice 6.1(d) ~~Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~End Date 9.1(b) Escrow Agent ~~2.16 Escrow Agreement 2.16~~ Preamble Escrow Fund ~~2.16~~ 8.7(a) Escrow Period 8.7(b)(i) Estimated Adjusted Merger Consideration 2.9(a)(iii) Estimated Closing Net Working Capital ~~Surplus 2.17(b~~2.9(b) ~~FDA Requirements 3.19(a~~Estimated Closing Net Working Capital Statement 2.9(b) Excess Expenses and Fees 6.8(a) Exchange Documents 2.10(c)(ii) Expense Escrow Fund 8.8(b) Export Approvals 3.21(b)(i) Fairness Hearing Law 6.1(a) Final ~~Working Capital 2.17(e~~Adjusted Merger Consideration 2.9(a)(iv) ~~Firm 11.9 FTC 6.2(a~~Final Surviving Entity 2.1(b) Financials 3.6(a) FIRPTA Compliance Certificate 6.15 Capitalized Term Section First Step Merger Recitals Fundamental Representations ~~10.2(a)(ii~~7.2(a)(ii) ~~HSR Act 6.2(a~~Hearing 6.1(a) ~~Indemnified D&Os 6.4(a~~Indemnifiable Matters 8.2(a) Indemnified Parties ~~10.1(a~~8.2(a) Indemnified Party 8.2(a) Indemnifying Party 8.2(a) Independent Accounting Firm 2.9(c)(iii)(B) Information Statement 6.1(b) Intellectual Property Assets 3.11(a)(x) Interim ~~Balance Sheet 3.9(b~~Financials 3.6(a) Interim ~~Balance Sheet Date 3.9(b~~Surviving Entity 2.1(a) ~~Interim Financial Statements 3.9(b) In~~Key Employee Non-~~the~~Competition and Non-~~Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~Solicitation Agreements Recitals Key Employee Offer Letters Recitals Lease Agreements 3.10(b) Leased Real Property ~~3.14(a~~3.10(a) ~~Letter Amendment Premable~~ Letter of Transmittal ~~2.12(a~~2.10(c)(i) ~~License~~ Licenses In 3.11(a)(xi) Licenses Out 3.11(a)(xii) Loss 8.2(a) Losses 8.2(a) Marks 3.11(a)(x) Material Contract 3.13(a) Material Contracts 3.13(a) Merger Recitals Merger Sub One Preamble Merger Sub Two Preamble Merger Subs Preamble Minimum Permit Period 6.1(d) Notice 6.1(a) Notice of Dispute 2.9(c)(ii) Offered Employees 6.11 Objection Deadline 8.5(b)(i) Objection Notice 8.5(b)(i) Option Bonus Agreement ~~3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble~~ 6.24 Option Bonus Agreement Amounts 6.7 Option Cancellation Agreement ~~2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b~~2.7(f)(ii) Parent Preamble Parent ~~Closing Balance Sheet 2.17(c~~SEC Reports 4.8 Patents 3.11(a)(x) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c~~PEO Arrangement 6.12(b) ~~Parent Working Capital Statement 2.17(c~~Permit Application 6.1(a) ~~Paying Agent 2.11(a~~Permit Filing Date 6.1(a) ~~Paying Agent Agreement 2.11(a~~Personal Data 3.11(a)(xiv) ~~Payment Fund 2.11(a~~Restrictive Contracts 3.11(h) ~~Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a~~Second Step Merger Recitals Section 280G Payments 6.9 Section 409A 3.9(e) ~~Preliminary Closing Statement 2.17(a~~Securities Act 3.2(g) ~~Prior Merger Agreement~~ Shareholder Notice 6.1(h) Shareholder Representative Preamble ~~Related Agreements 3.5(a~~Shareholder Representative Certificate 8.8(b) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Capitalized Term Section Shareholder Representative Expenses 8.8(b) Shortfall Amount 2.10(d) Soliciting Materials 6.1(g) Specified ~~Representations 10.2(a)(iii~~Bonuses 3.19(a) ~~▇▇▇▇▇ Law 3.12(b~~Spreadsheet 6.14 Stand-down Period 8.6 Standard Sales Agreements 3.11(a)(xii) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Standards Body 3.11(a)(xv) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Statement of Expenses 6.8(a) Survival Date ~~10.3(a~~8.1(a) Systems 3.11(a)(xvi) Tail Policy 6.23(b) Target Working Capital Amount 2.9(a)(v) Tax 3.9(a) Tax Contest 6.16(d) Tax Incentive 3.9(b)(xv) Tax Service Provider 6.16(d) Taxes 3.9(a) Terminated Agreements 6.7 Third Party Claim 8.6 Third Party Expenses 6.8(a) Third Party IP Assets 3.11(c)(v) Threshold 8.3(b) Trade Secrets 3.11(a)(xvii) Transfer Taxes 6.16(c) Treasury Regulations Recitals Unobjected Claim ~~10.4(b~~8.5(b)(ii) Unresolved Claims 8.7(b)(iii) Unvested Option Cashout 2.7(f)(ii) User Data 3.11(a)(xviii) Voting Agreement or Voting Agreements Recitals Working Capital ~~Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Memorandum 2.9(c)(iii)(A)

Appears in 1 contract

Sources: Merger Agreement (Solarcity Corp)

Additional Defined Terms. ~~The following~~ In addition to the terms ~~shall have the meanings set forth on the pages~~ defined in Section 1 of this Appendix A, the following capitalized terms are defined in the body of the Agreement where indicated below: ~~280G Approval 6.3(c~~Accounting Referee 14.1(e) ~~280G Payments 6.3(c~~Acquired Assets 2.2 Acquired Interests 2.3(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Acquired Leases 2.3(a) Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Allocated Value 3.5 Asset 3.5 Assignment 13.3(a) ~~Audited Balance Sheet 3.9(b~~Background Materials 9.9(a) ~~Audited Balance Sheet Date 3.9(b~~Base Purchase Price 3.1(a)(i) ~~Audited Financial Statements 3.9(b~~BOEPD 3.2(b)(iv) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Change-In-Interest 5.2(a) Claim Notice 16.3(a) Closing ~~2.4~~ 13.1(b) Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~13.1(b) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Confidential Information 10.13(b) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) Consent Decree Excluded ▇▇▇▇▇ ~~Law 3.12(b~~10.21 Consent Decree ▇▇▇▇▇ 2.4(a) ~~Stockholder~~ Defect Adjustment 5.6(c) Defect Notice Deadline 5.5(a) Defensible Title 5.1 Deposit 3.3 Deposit Escrow Account 3.3 Deposit Escrow Agreement 3.3 Disclosed Environmental Matters 8.5 DTPA 17.4 Due Diligence Review 4.1(a) Environmental Assessment 6.1(b) Environmental Defect 6.2 Environmental Defect Value 6.3 Environmental Disputed Matters 6.8 Environmental Matters 6.9 Escrow Agent 3.3 Exchange Transaction 15.7(a) Exchanging Party 15.7(a) Excluded Assets 2.5 Execution Date Preamble Final Determination Date 14.1(i) Final First Closing Purchase Price 14.1(a) Final Purchase Price 14.1(b) Final Second Closing Purchase Price 14.1(b) Final Settlement Disputes 14.1(e) First Closing 13.1(a) First Closing Amount 3.4(b)(i) First Closing Assets 2.3 First Closing Assets Contracts 2.3(h) First Closing Assets Data 2.3(j) First Closing Assets Records 2.3(m) First Closing Assignment 13.2(a) First Closing Base Purchase Price 3.1(a)(ii) First Closing Date 13.1(a) First Closing Final Settlement Statement 14.1(a) First Closing Payment 3.4(b)(i)(A) First Closing Properties 2.3(c) First Closing Purchase Price 3.1(a)(iii) First Closing Settlement Date 14.1(a) First Closing Transition Services Agreement 13.2(l) First Closing ▇▇▇▇▇ 2.3(c) First Preliminary Settlement Statement 3.4(a)(i) Indemnified Party 16.3(a) Indemnifying Party 16.3(a) Information Request 10.13(c) Interest Addition 5.8(a) Interest Addition Amount 5.6(c) Interim Operation Approval ~~3.8 Stockholder Meeting 5.8(b~~Threshold 10.1(a) ~~Straddle~~ Intermediary 15.7(c) Joint Use Agreement 13.2(k)) Lands 2.3(b) Leased Lands 2.3(a) Material First Closing Assets Contracts 2.3(h) Material Second Closing Assets Contracts 2.4(f) NBLX Contracts 10.22 Negotiation Period ~~1.1 Subsidiary Securities 3.2(b~~14.1(d) ~~Survival~~ Net Aggregate Defect Value 5.6(c) Non-Consent Decree ▇▇▇▇▇ 2.4(a) Non-Exchanging Party 15.7(a) NORM 6.2 Notice of Environmental Defects 6.4(b) Notice of Title Defects 5.5(a) Objection 10.13(c) Objection Date ~~10.3(a~~14.1(c) ~~Third~~ Objection Report 14.1(c) Oil and Gas Property Taxes 15.1(a) Open Environmental Defect 6.6(a) Open Title Defect 5.7(a) Other Property Taxes 15.1(b) Party Preamble Parties Preamble Permitted Lien 5.2 Phase II Request 6.1(b)(ii) Production Values 3.2(b)(iv) Purchase Price 3.1(a)(iv) Purchaser Preamble Purchaser Defect Termination Notice 6.7(a) Purchaser’s Title Defect Value 5.6(b) S-X Financials 10.20 Second Closing 13.1(b) Second Closing Amount 3.4(b)(ii) Second Closing Assets 2.4 Second Closing Assets Contracts 2.4(f) Second Closing Assets Data 2.4(h) Second Closing Assets Records 2.4(k) Second Closing Assignment 13.3(a) Second Closing Base Purchase Price 3.1(a)(v) Second Closing Date 13.1(b) Second Closing Final Settlement Statement 14.1(b) Second Closing Payment 3.4(b)(ii) Second Closing Properties 2.4(a) Second Closing Purchase Price 3.1(a)(vi) Second Closing Settlement Date 14.1(b) Second Closing Transition Services Agreement 13.3(c) Second Closing ▇▇▇▇▇ 2.4(a) Second Preliminary Settlement Statement 3.4(a)(ii) Seller Preamble Seller’s Warranties 17.16(b) Settled Asset Taxes 15.2 Settled Oil and Gas Property Taxes 15.1(a) Settled Other Property Taxes 15.1(b) Settled Property Taxes 15.1(b) Settled Severance Taxes 15.2 Subject Consent Decree ▇▇▇▇▇ 10.21 Surviving Environmental Defect 6.5(b) Surviving Title Defect 5.6(b) Tax Controversy 15.8(d) Termination Dispute Notice 6.8(b) Termination Response Notice 6.8(b) Third-Party Claim ~~10.4(b~~16.3(b) ~~Working Capital Deficit 2.17(f~~Title Defect 5.3 Title Defect Value 5.4 Title Disputed Matters 5.9 Title/Environmental Termination Threshold 6.7(a) ~~Working Capital Objection Period 2.17(e~~Title LLC 15.7(d) ~~Working Capital Objection Statement 2.17(e~~Unagreed Termination Environmental Matters 6.7(b) ~~Working Capital Surplus 2.17(f)~~Unagreed Termination Title Matters 6.7(b) Wellbore Notice 10.21 Neither these Schedules nor any disclosure made in or by virtue of them constitutes or implies any representation, warranty, or covenant by Seller not expressly set out in the Agreement, and neither these Schedules nor any such disclosure has the effect of, or may be construed as, adding to, broadening, deleting from or revising the scope of any of the representations, warranties, or covenants of Seller in the Agreement. Any item or matter disclosed or listed on any particular Schedule is deemed to be disclosed or listed on any other Schedules to the extent it is reasonably apparent that such item relates or is applicable to, or is properly disclosed under, such other Schedule or the section of the Agreement to which such other Schedule corresponds, notwithstanding the fact that the Schedules are arranged to correspond to the sections of the Agreement, that a particular section of the Agreement makes reference to a particular Schedule, or that a particular representation, warranty or covenant in the Agreement may not make reference to a Schedule. Matters reflected in these Schedules are not necessarily limited to matters required by the Agreement to be reflected in these Schedules. The fact that any item of information is contained herein is not an admission of liability under any applicable law, and does not mean that such information is required to be disclosed in or by the Agreement, or that such information is material, but rather is intended only to qualify the representations, warranties and covenants in the Agreement and to set forth other information required by the Agreement. Neither the specification of any dollar amount in any representation, warranty or covenant contained in the Agreement nor the inclusion of any specific item in these Schedules is intended to imply that such amount, or a higher or lower amount, or the item so included, or any other item, is or is not material, and no party shall use the setting forth of any such amount or the inclusion of any such item in any dispute or controversy between or among the parties to the Agreement as to whether any obligation, item or matter not described herein or included in these Schedules is or is not material for purposes of the Agreement. The information set forth on the Schedules shall not be used as a basis for interpreting the terms “material”, “materially”, “materiality”, “Material Adverse Effect”, or any similar qualification in the Agreement. Neither the specification of any item or matter in any representation, warranty or covenant contained in the Agreement nor the inclusion of any specific item in these Schedules is intended to imply that such item or matter, or another item or matter, is or is not in the ordinary course of business, and no party shall use the setting forth or the inclusion of any such item or matter in any dispute or controversy between or among the parties to the Agreement as to whether any obligation, item or matter described or not described herein or included or not included in these Schedules is or is not in the ordinary course of business for purposes of the Agreement. Headings have been inserted in these Schedules for reference only and do not amend the descriptions of the disclosed items set forth in the Agreement. Where a reference is made to a section or exhibit, such reference shall be to a section of or exhibit to the Agreement unless otherwise indicated. Whenever the words “include,” “includes,” or “including” are used in these Schedules, they shall be deemed to be followed by the words “without limitation,” whether or not they are in fact followed by those words or words of like import. The following Schedules constitute Seller’s Disclosure Schedules: 8.1 Material Required Consents 8.2 Preferential Rights

Appears in 1 contract

Sources: Purchase and Sale Agreement (SRC Energy Inc.)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Index of Terms Section Agreement Preamble ~~Agreement Date~~ Assumed Accounts Payable 1.5(a) Asset Purchase Recitals Assumed Liabilities 1.5(a) Assumed Warranty Claims 1.5(a) Basket Amount 7.2(b) Bill of Sale 1.7(c)(2) Business Authorizati▇▇▇ 2.17 Buyer Parent Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Buyer Party(ies) ~~Audited Balance Sheet 3.9(b~~Preamble Buyer Preamble Index of Terms Section Cash Amount 1.7(a) ~~Audited Balance Sheet Date 3.9(b~~Cap 7.3(c) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Charter Documents 2.1 Closing ~~2.4~~ 1.6 Closing Date 1.6 Confidentiality Agreement 5.2 Conflict 2.4 ~~Closing Working Capital Estimate 2.17(a~~Consultant Proprietary Information Agreement 2.9(q) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Contract(s) ~~Company~~ 2.4 Counsel 5.1(c) Disclosure Schedule ~~3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Article II Escrow Agreement 7.3(a) ~~Company Preferred Stock 2.10(b~~Escrow Amount 7.3(a) ~~Company Representative 5.11 Company Software 3.18(l~~Escrow Fund 7.3(a) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(hEscrow Period 7.3(b) Employee ~~Plan 3.15(h~~Proprietary Information Agreement 2.9(q) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(aExcluded Assets 1.4 GAAP 2.11 Inbound-Licenses 2.9(j) Indemnified Parties ~~10.1(a~~7.2(a) ~~Interim Balance Sheet 3.9(b~~Indemnifying Parties 7.2(a) ~~Interim Balance Sheet Date 3.9(b~~IP Contracts 2.9(k) ~~Interim Financial Statements 3.9(b~~IP Recordation Agreements 1.7(c)(ii) ~~In-the-Money Company Option 2.13(a~~Key Employee Employment Agreement 1.5(c) ~~In-the-Money Company Warrant 2.14(a~~Lease Agreements 2.8(a) Leased Real Property ~~3.14(a~~2.8(a) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Loss(es) 7.2(a) Material Contracts 2.10(a) Malware 2.9(w) Non-Assignable Asset 5.1(e) Non-Paying Party 5.5(b)(iii) Objection Notice 7.4(a) Officer’s Certificate 7.4(a) Open Source License ~~Agreement 3.16(a)(xi~~1.1 Other Tax Controversy 7.4(c) ~~License Agreements 3.16(a)(xi~~Outbound-Licenses 2.9(j) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(bPaying Party 5.5(b)(iii) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(aPlan 5.7(e) Pre-Closing ~~Period 6.1 Preliminary Closing Balance Sheet 2.17(a~~Tax Controversy 7.4(c) ~~Preliminary Closing Statement 2.17(a~~Projections 2.11 Purchase Price 1.7(a) ~~Prior Merger Agreement~~ Purchased Assets 1.3(h) Regular Quarterly Financial Information 2.11 Retained Liabilities 1.5(b) Returns 2.6(b) Index of Terms Section Seller Preamble ~~Related Agreements 3.5(a~~Seller Parties Preamble Seller Secretary Certificate 6.2(f) Seller ~~Group 11.19 Series D Stock 1.1~~ Sub Preamble Special Representations ~~10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b)~~ 7.1 Straddle Period ~~1.1 Subsidiary Securities 3.2(b~~Tax 5.5(b)(iii) Survival Date ~~10.3(a~~7.1 Tax(es) 2.6(a) Third Party Claim ~~10.4(b~~7.4(b) ~~Working Capital Deficit 2.17(f~~Third Party Expenses 5.3 Transferred Employees 5.7(a) ~~Working Capital Objection Period 2.17(e~~Transfer Taxes 5.5(a) ~~Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~WARN 2.21(e)

Appears in 1 contract

Sources: Asset Purchase Agreement (INPHI Corp)

Additional Defined Terms. ~~The following~~ In addition to the terms defined in Section 1.1, additional defined terms used herein shall have the respective meanings ~~set forth on~~ assigned thereto in the ~~pages of this Agreement~~ Sections indicated below~~: 280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ . Defined Term Section Agreed Claims ~~10.4(g~~8.6(d) Agreement Preamble ~~Agreement~~ Allocation 3.2(a) Anti-Corruption Laws 4.8(b) Assumed Liabilities 2.3 Canadian JV End Date ~~Preamble Allocation~~ 6.10(b) Claim Certificate ~~6.8 Antitrust Filings 6.2(a~~8.6(a) ~~Audited Balance Sheet 3.9(b~~Closing 3.3(a) ~~Audited Balance Sheet Date 3.9(b~~Closing Amount 3.1(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~3.3(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Collateral Source 8.5(a) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(fControlled Registered IP 4.12 Effect 1.1 End Date 9.1(b)(ii) Escrow ~~Agent 2.16~~ Account 6.10(c) Escrow Agreement ~~2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b~~3.1(b) ~~FDA Requirements 3.19(a)~~ Excluded Assets 2.2 Excluded Liabilities 2.4 Final ~~Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~Reconciliation 2.7(a) Fundamental Representations ~~10.2(a)(ii~~8.1 General Cap 8.4 Guarantor Recitals Icon NY Preamble Iconix Latin America Preamble Indemnified Party 8.6(a) ~~HSR Act 6.2(a~~Indemnifying Party 8.6(a) ~~Indemnified D&Os 6.4(a~~JV Asset Amount 3.1(b) ~~Indemnified Parties 10.1(a~~JV Asset Closing 2.6(b) (a) ~~Interim Balance Sheet 3.9(b~~JV Business 6.2(b) ~~Interim Balance Sheet Date 3.9(b~~JV Liabilities 6.10(a) ~~Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter~~ Knowledge of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent 1.5 Knowledge of Purchaser 1.5 Knowledge of Sellers 1.5 Limited Guaranty Recitals Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) PrePost-Closing ~~Period 6.1 Preliminary~~ Acquisition 6.10(a) Post-Closing ~~Balance Sheet 2.17(a~~Acquisition End Date 6.10(b) ~~Preliminary Closing Statement 2.17(a~~Purchase Recitals Purchase Price 3.1 Purchased Assets 2.1 Purchaser Preamble Purchaser Disclosure Letter Article V Purchaser Indemnitees 8.2 Remaining JV Escrow Amount 6.10(b) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Royalties 2.7(a) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Indemnitees 8.3 Sellers Preamble Sellers Disclosure Letter Article IV Sharper Image Holdings Preamble Synthetic Acquisition 6.10(b) ~~Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third~~ Top Licensees 4.13 Third-Party Claim ~~10.4(b~~8.7(a) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Transfer Taxes 6.7(a)

Appears in 1 contract

Sources: Asset Purchase Agreement (Iconix Brand Group, Inc.)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: 280G Approval ~~6.3(c~~6.1(h) 280G ~~Payments 6.3(c~~Waiver 7.2(c)(i) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~401(k) ~~Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings~~ Plan 6.14 Agents 6.2(a) ~~Audited Balance Sheet 3.9(b~~Applicable Expiration Date 8.1(a) Assumed Equity 2.7(f)(i) Audited Financials 3.7 Balance Sheet Date ~~3.9(b) Audited Financial Statements 3.9(b~~3.7 California Commissioner 6.1(a) California ~~Stockholder Approval 3.8~~ Permit 6.1(a) Cancelled Equity 2.7(f)(ii) Cash Payment 2.7(f)(ii) CCC 2.8(a) Certificate of Incorporation 3.1(a) Certificate of Merger ~~2.4 Claims 10.4 CLIA 1.1~~ 2.3(a) Certificates of Mergers 2.3(b) Change of Control Fees 6.10 Change of Recommendation Notice 6.2(d)(ii) Charter Documents 3.1(a) Claim Certificate 8.5(a) Closing ~~2.4~~ 2.1(c) Closing 2.2 Closing Date ~~2.4~~ 2.2 Closing Working Capital ~~Estimate 2.17(a~~2.9(a)(i) Company ~~Preamble~~ Auditors 3.7 Company ~~Board Approval 3.5 Company Certificate 2.10(e)~~ Authorizations 3.18 Company Disclosure Schedule ~~3.0~~ Article III Company ~~Disclosure Schedules 3.0 Company Option 2.13(a~~Indemnifiable Matters 8.2(b) Company ~~Preferred Stock 2.10(b~~Indemnified Parties 8.2(b) Company ~~Representative 5.11 Company Software 3.18(l~~Indemnified Party 8.2(b) Company ~~Third Party Consents 6.3(b~~Indemnifying Parties 8.2(a) Company ~~Warrant 2.14(a~~Indemnified Party 8.2(a) Company ~~Warrant Documents 2.12(a~~Registered Intellectual Property 3.15(a) ~~Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~Company Stock Certificates 2.10(b)(ii) ~~Delivered Tax Returns 3.22(a~~Company Stockholders’ Meeting 6.1(g) ~~DGCL Preamble Disclosure~~ Company’s Closing Working Capital Statement ~~5.8(a~~2.9(a)(i) Conflict 3.5 Consent and Modification Fees 6.10 Contaminants 3.15(n) Contract Termination Fees 6.10 Current Balance Sheet 3.7 Current Parent SEC Filings 4.8 Director and Officer Resignation Letter 6.11(e) Dissenting Share Payments 2.8(c) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15~~ 2.8(a) DOJ ~~6.2(a)~~ 3.6 Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~2.3(a) Election Notice 6.1(c) End Date 9.1(b) Escrow Agreement 2.10(a) Escrow Expenses 8.7(b) Excess Amount 2.10(c)(ii) Exchange Documents 2.10(b)(ii) Expiration Date 8.1(a) Fairness Hearing Law 6.1(a) Final Adjusted Closing Cash Consideration 2.9(b)(v) Final Closing Working Capital 2.9(b)(iv)(C) Final Surviving Entity 2.1(b) Financials 3.7 Foreign Employees 3.23(i) FTC 3.6 Funded International Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a3.23(h) Indemnified Parties ~~10.1(a~~8.2(b) ~~Interim Balance Sheet 3.9(b~~Indemnifying Parties 8.2(b) ~~Interim Balance Sheet Date 3.9(b~~Independent Accounting Firm 2.9(b)(iv)(B) ~~Interim Financial Statements 3.9(b~~Independent Accounting Firm Expenses 2.9(b)(iv)(B) Information Statement 6.1(a) In-~~the-Money Company Option 2.13(a~~Licenses 3.15(i) ~~In-the-Money Company Warrant 2.14(a~~Interim Financials 3.7 Interim Surviving Entity 2.1(a) IP Contracts 3.15(j) Lease Agreements 3.14(b) Leased Real Property 3.14(a) Letter ~~Amendment Premable Letter~~ of Transmittal ~~2.12(a~~2.10(b)(i) ~~License Agreement 3.16(a)(xi~~Litigation Claim 3.19 Loss 8.2(a) ~~License Agreements 3.16(a)(xi~~Losses 8.2(a) ~~Majority Effective Time Holders 9.1(c~~Material Contract 3.16(a) ~~Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c~~Material Contracts 3.16(a) ~~Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b~~Objection Notice 8.5(b) Offer Letter 6.12(a) Out-~~of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b~~Licenses 3.15(j) Parent ~~Preamble Parent Closing Balance Sheet 2.17(c~~Capital Stock 4.12(a) Parent ~~Representatives 5.9~~ Certificate of Incorporation 4.1 Parent ~~Working Capital Determination 2.17(c~~Charter Documents 4.1 Parent Disclosure Schedule Article IV Parent Indemnifiable Matters 8.2(a) Parent Indemnified Parties 8.2(a) Parent Indemnified Party 8.2(a) Parent Indemnifying Parties 8.2(b) Parent Indemnifying Party 8.2(b) Parent Options 4.12(c) Parent Preferred Stock 4.12(a) Parent RSUs 4.12(c) Parent SEC Filings 4.8 Parent’s Closing Working Capital Statement ~~2.17(c~~2.9(b)(i) ~~Paying Agent 2.11(a~~Plexus 3.16(a)(x) ~~Paying Agent Agreement 2.11(a) Payment Fund 2.11(a~~Post-Closing Notice of Dispute 2.9(b)(ii) Pre-Closing Period ~~6.1 Preliminary~~ 5.1 Pre-Closing ~~Balance Sheet 2.17(a~~Returns 6.16(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital ~~Deficit 2.17(f~~2.9(a)(i) ~~Working Capital Objection Period 2.17(e~~Proprietary Information Agreement 3.15(h) ~~Working Capital Objection Statement 2.17(e~~Representative Expenses 8.8(b) ~~Working Capital Surplus 2.17(f~~Section 280G Payments 6.1(h) Section 409A 3.12(e) Securities Act 4.8 Shortfall Amount 2.10(c)(i)

Appears in 1 contract

Sources: Agreement and Plan of Reorganization (Harmonic Inc)

Additional Defined Terms. ~~The~~ In addition, for the purpose of this Agreement, the following terms shall have the following meanings set forth on in the ~~pages of this Agreement indicated below~~Sections indicated: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ Agreed ~~Claims 10.4(g~~Procedures 6.1(a) Agreement Preamble ~~Agreement Date Preamble~~ APIs See definition of SpinCo Business, 1.1 Authorized Representative 7.2 Bankruptcy Code 8.5(h) Base Proceeds 3.4(e) Bulk Request 6.1(b) Cash Allocation ~~Certificate 6.8 Antitrust Filings 6.2(a~~3.4(f)(ii) ~~Audited Balance Sheet 3.9(b~~CEO Negotiation Request 7.3 Chosen Courts 10.2(b) ~~Audited Balance Sheet Date 3.9(b~~Commingled Excluded Information 6.11 Contribution Recitals control See definition of Affiliate, 1.1 controlled by See definition of Affiliate, 1.1 Covered Parent Patent 8.4 Covered SpinCo Patent 8.4 CPR 7.4 Delayed Parent Asset 2.4(h) ~~Audited Financial Statements 3.9(b~~Delayed Parent Liability 2.4(h) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a~~Delayed SpinCo Asset 2.4(c) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Delayed SpinCo Liability 2.4(c) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Dispute 7.1 e-mail 10.5 Encumbrances 3.4(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(aEndo Recitals Excess Proceeds 3.4(f) Final ~~Working Capital 2.17(e~~Stock Allocation 3.4(k)(i) ~~Firm 11.9 FTC 6.2(a~~Indemnifying Party 4.4(a) ~~Fundamental Representations 10.2(a)(ii~~Indemnitee 4.4(a) ~~HSR Act 6.2(a~~Indemnity Payment 4.4(a) ~~Indemnified D&Os 6.4(a~~Initial Cash Allocation 3.4(e)(ii) ~~Indemnified Parties 10.1(a~~Initial Notice 7.1 Initial SpinCo Allocation 3.4(e)(i) Institutional Accredited Investor See definition of Qualified Shareholder, 1.1 Interim Excess Determination 3.4(l) Interim ~~Balance Sheet 3.9(b~~Excess Proceeds 3.4(l) ~~Interim Balance Sheet Date 3.9(b~~Internet Properties See definition of Intellectual Property Rights, 1.1 Licensees 8.5(d) ~~Interim Financial Statements 3.9(b~~Licensors 8.5(d) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Mediation Request 7.4 Merger ~~Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b)~~ Recitals Merger Sub Recitals Officer Negotiation Request 7.2 Parent Preamble Parent ~~Closing Balance Sheet 2.17(c~~Accounts 2.9(a) Parent ~~Representatives 5.9 Parent Working Capital Determination 2.17(c~~Assets 2.2(b) Parent ~~Working Capital Statement 2.17(c~~Board Recitals Parent Books and Records 2.2(a)(xiii) ~~Paying Agent 2.11(a~~Parent Indemnitees 4.2 Parent Liabilities 2.3(b) ~~Paying Agent Agreement 2.11(a~~Parent SpinCo Share 3.4(h) ~~Payment Fund 2.11(a~~Parent Transferred Entity/Subsidiary Liability 2.1(a) Patents See definition of Intellectual Property Rights, 1.1 Pre-~~Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a~~Redemption Notification Deadline 3.4(g) ~~Preliminary Closing Statement 2.17(a~~Procedure 7.4 Prohibited Business 8.3(c) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Qualified Institutional Buyer See definition of Qualified Shareholder, 1.1 Redemption 3.4(a) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Redemption Consideration 3.4(c) Removed Party 2.7(b) Separation Recitals Separation Step Plan 2.1(a) Specified ~~Representations 10.2(a)(iii~~Ancillary Agreement 10.18(b) ~~▇▇▇▇▇ Law 3.12(b~~SpinCo Preamble SpinCo Accounts 2.9(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~SpinCo Allocation 3.4(f)(i) ~~Straddle Period~~ SpinCo Assets 2.2(a) SpinCo Financing Arrangements 2.12 SpinCo Indemnitees 4.3 SpinCo Liabilities 2.3(a) SpinCo Real Property Leases See definition of SpinCo Real Property, 1.1 SpinCo Retained Cash Amount 2.2(b)(ix) SpinCo Transferred Entity/Subsidiary ~~Securities 3.2(b~~Liability 2.1(a) ~~Survival Date 10.3(a) Third~~ Third-Party Claim ~~10.4(b~~4.5(a) ~~Working Capital Deficit 2.17(f~~Trade Secrets See definition of Intellectual Property Rights, 1.1 Trademarks See definition of Intellectual Property Rights, 1.1 Transfer Documents 2.1(c) ~~Working Capital Objection Period 2.17(e~~Transition Committee 2.13 under common control with See definition of Affiliate, 1.1 Unreleased Parent Liability 2.5(b)(ii) ~~Working Capital Objection Statement 2.17(e~~Unreleased SpinCo Liability 2.5(a)(ii) ~~Working Capital Surplus 2.17(f~~Valuation Advice 3.2(b)

Appears in 1 contract

Sources: Separation Agreement (Mallinckrodt PLC)

Additional Defined Terms. ~~The following~~ In addition to the terms defined in Section 1.1, additional defined terms used herein shall have the respective meanings ~~set forth on~~ assigned thereto in the ~~pages of this Agreement~~ Sections indicated below~~: 280G Approval 6.3(c~~. Acquisition Financials 6.24 Additional Pay 6.8(a) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ Affected Assets 6.12 Agreed Claims ~~10.4(g~~8.6(e) Agreement Preamble ~~Agreement Date Preamble~~ Allocation 3.3 Appraisal Value 6.12(b)(iii) Arbitrator 3.2(c)(i) Assumed Liabilities 2.3 Bifurcated Purchase Price 2.7(b) Business Permits 2.1(e) Carved-Out Assets 2.7(b) Carved-Out Assets and Liabilities 2.7(b) Casualty Loss 6.12 CCCL 10.11(c) Claim Certificate ~~6.8 Antitrust Filings 6.2(a~~8.6(a) ~~Audited Balance Sheet 3.9(b~~Closing 3.4(a) ~~Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date ~~2.4~~ 3.4(a) Closing Statement 3.2(a) COBRA 6.8(f) Collateral Source 8.5(a) Combined Historical Summary 4.17(b) Comparable Position 6.8(a) Consent Decree Modification 6.3(m) Conveyance Documents 3.4(b)(iii) Conveyed Entity Contracts 4.6 Covered Assets and Persons 6.13(a) Disputed Amounts 3.2(c) Divestiture 6.3(e) Employee Benefit Plans 4.9(a) End Date 9.1(b)(ii) Environmental Losses 8.8(b) Environmental Release 8.8(b) ERISA 4.9(a) Estimated Closing Purchased St. Lucia HydrocarbonInventory Value 3.1(a) Estimated Closing St. Lucia Working Capital ~~Estimate 2.17(a~~3.1(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Estimated Closing Statement 3.1(a) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time Excluded Assets 2.2 Excluded Liabilities 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(aField Inspector 6.21(a) Final ~~Working Capital 2.17(e~~Purchase Price 3.2(d) ~~Firm 11.9 FTC 6.2(a~~Final Purchase Price Adjustment 3.2(d) ~~Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Hess Foundation Parcel 6.23(b) Indemnified ~~D&Os 6.4(a~~Party 8.6(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 8.6(a) ~~Interim Balance Sheet 3.9(b~~Knowledge of Purchaser 1.5 Knowledge of Seller 1.5 Leftover Product 6.21(c) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter~~ Notice of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities Objection 3.2(b) ~~Survival Date 10.3(a~~Owned Real Property 4.5(a) ~~Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Permits 4.15 Port Reading Decommissioning 6.19

Appears in 1 contract

Sources: Purchase and Sale Agreement

Appears in 1 contract

Sources: Merger Agreement

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ Section of this Agreement ~~indicated~~ set forth opposite each such respective term below: ~~280G Approval 6.3(c~~Agreement Introduction Alternative Arrangements 9.3 (a) ~~280G Payments 6.3(c~~Annual Financial Statements 3.5 (a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Basket Amount 9.3 (a) ~~Agreement Preamble Agreement~~ Books and Records 3.20 Buyer Introduction Buyer Obligations 11.1 CBB Obligations 11.4 Closing 2.5 (a) Closing Cash Payment 2.2 (a) Closing Date ~~Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.5 (a) ~~Audited~~ Company Introduction Company Balance Sheet ~~3.9(b~~3.5 (a) ~~Audited~~ Company Balance Sheet Date ~~3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a~~3.5 (a) Company ~~Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Foreign Employee 7.3 (b) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(aCompeting Transaction 6.3 (a) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~7.13 (a) ~~Delivered Tax Returns 3.22(a~~Confidential Information 7.13 (c) ~~DGCL Preamble~~ Continuing Employees 7.9 Converted Options 2.4 (a) Deferred Share Agreement 2.4 (e) Deferred Shares 2.4 (e) Delaware Court 11.7 Director Resignation Letter 7.3 (a) Disclosure ~~Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a)~~ Schedule Article III Effective Time 2.4 ~~Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~(a) Escrow Agent ~~2.16~~ 2.5(b)(ii)(2) Escrow Agreement ~~2.16~~ 2.5(b)(ii)(2) Escrow Fund ~~2.16 Estimated Working Capital Surplus 2.17(b~~2.5(b)(ii)(2) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Excess Third Party Expenses 2.3 Financial Statements ~~3.9(b~~3.5 (a) Generally Available Commercial Code 3.12 (b) Grootaers Guarantee 11.4 Holdback Amount 9.4 (c) Identified Sellers 7.14 (a) In-~~the-Money Company Option 2.13(a~~bound IP Agreements 3.12 (b) ~~In-the-Money Company Warrant 2.14(a~~Indemnified Party or Indemnified Parties 9.2 (a) Leased Real Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b3.10 Leases 3.10 Loss or Losses 9.2 Material Contracts 3.13 OEM Partners 3.21 (a) Out-~~of-the-Money Company Warrant 2.14(b~~bound IP Agreements 3.12 (b) ~~Outside Date 8.1(b~~Owned Depository Receipts 4.4 Owned Options 4.4 Parent Guarantee 11.1 Party or Parties Introduction Payment Notice 9.4 (b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Permitted Transfer 6.4 Pre-Closing Tax Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a~~3.9 (c) ~~Preliminary Closing Statement 2.17(a~~Released Claims 7.12 Released Parties 7.12 Releasor Parties 7.12 Remaining Escrow Amount 9.4 (c) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Resolved Claim 9.4 (c) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Approval 4.3 (a) Seller or Sellers Introduction Sellers’ Representative Introduction Sellers’ Representative Expenses 9.6 (c) Share Purchase Recitals Shares Recitals Specified Representations ~~10.2(a)(iii~~9.3 (a) ~~▇▇▇▇▇ Law 3.12(b~~Tax Ruling 2.4 (d) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival~~ Tax Rep Cutoff Date ~~10.3(a~~9.1 (a) Third Party Claim ~~10.4(b~~Notice 9.4 (d) ~~Working Capital Deficit 2.17(f~~Third Party Expenses Statement 2.3 Top Distributors 3.21 (a) ~~Working Capital Objection Period 2.17(e~~Transfer 6.4 Transfer Taxes 7.10 Unaudited Financial Statements 3.5 (a) ~~Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Withholding Certificate 2.6

Appears in 1 contract

Sources: Share Purchase Agreement (McAfee, Inc.)

Additional Defined Terms. ~~The~~ In addition to the terms defined in Section 1.1 above, the following additional defined terms ~~shall have~~ are defined in the ~~meanings~~ respective Section set forth ~~on the pages of this Agreement indicated~~ opposite such term below: ~~280G Approval 6.3(c) 280G Payments 6.3(c~~A&S Preamble Accountant 2.4(b) Acquisition ~~Proposal 5.11 Acquisition Sub~~ Claim 9.9 Action 3.11 Affiliate Transactions 3.19 ASKL Recitals ASREH Preamble ~~Agreed Claims 10.4(g~~Audited Financial Statements 3.8(a) ~~Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited Balance Sheet 3.9(b) Audited~~ Balance Sheet Date ~~3.9(b~~3.8(b) ~~Audited~~ Business Recitals Claim Notice 9.6 Closing 2.1 Closing Date 7.1 Company(ies) Preamble Company Intellectual Property 3.7(a) Deductible 9.4(a) Excluded Assets 6.4(a) Final Purchase Price 2.5(e) Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a3.8(b) Fundamental ~~Representations 10.2(a)(ii~~Cap 9.4(b) ~~HSR Act 6.2(a~~General Cap 9.4(b) ~~Indemnified D&Os 6.4(a~~Holdback Amount 2.3(a) ~~Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b)~~ HVEC Preamble Interim Financial Statements ~~3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~3.8(b) Leased Real Property ~~3.14(a~~3.5(b) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Liability Policies 6.3 Licensed Intellectual Property 3.7(b) ~~License Agreement 3.16(a)(xi~~Material Customer 3.20(a) ~~License Agreements 3.16(a)(xi~~Material Supplier 3.20(b) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) Membership Interests Recitals M▇▇▇▇▇ ~~Law 3.12(b~~& M▇▇▇▇▇ 10.15 Notice of Dispute 2.5(b) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Open Claim 2.3(c) ~~Straddle~~ Owned Real Property 3.5(a) Permits 3.18(a) Pro-Rata Share 9.2(a) Proprietary Information 6.1(b) Purchase Price 2.2(a) Purchaser Preamble DEFINED TERM SECTION Purchaser Indemnified Parties 9.2(a) Records 6.2(a) Required Consents 3.4 Resolution Period ~~1.1~~ 2.5(b) Run-Off Insurance Policies 6.3 Seller or Sellers Preamble Seller Indemnified Parties 9.3 Seller Representative Preamble Sellers’ Account 2.2(b)(iv) Subsidiary ~~Securities 3.2(b) Survival Date 10.3(a) Third~~ Recitals Third-Party Claim ~~10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~9.7 WARN 3.16(b)

Appears in 1 contract

Sources: Membership Interest Purchase Agreement (Celadon Group Inc)

Additional Defined Terms. ~~The following~~ In addition to the terms defined in Section 1.1, additional defined terms used herein shall have the respective meanings ~~set forth on~~ assigned thereto in the ~~pages of this Agreement~~ Sections indicated below~~: 280G Approval 6.3(c~~. Acquisition Financials 6.24 Additional Pay 6.8(a) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ Affected Assets 6.12 Agreed Claims ~~10.4(g~~8.6(e) Agreement Preamble ~~Agreement Date Preamble~~ Allocation 3.3 Appraisal Value 6.12(b)(iii) Arbitrator 3.2(c)(i) Assumed Liabilities 2.3 Bifurcated Purchase Price 2.7(b) Business Permits 2.1(e) Carved-Out Assets 2.7(b) Carved-Out Assets and Liabilities 2.7(b) Casualty Loss 6.12 CCCL 10.11(c) Claim Certificate ~~6.8 Antitrust Filings 6.2(a~~8.6(a) ~~Audited Balance Sheet 3.9(b~~Closing 3.4(a) ~~Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date ~~2.4~~ 3.4(a) Closing Statement 3.2(a) COBRA 6.8(f) Collateral Source 8.5(a) Combined Historical Summary 4.17(b) Comparable Position 6.8(a) Consent Decree Modification 6.3(m) Conveyance Documents 3.4(b)(iii) Conveyed Entity Contracts 4.6 Covered Assets and Persons 6.13(a) Disputed Amounts 3.2(c) Divestiture 6.3(e) Employee Benefit Plans 4.9(a) End Date 9.1(b)(ii) Environmental Losses 8.8(b) Environmental Release 8.8(b) ERISA 4.9(a) Estimated Closing Purchased St. Lucia Hydrocarbon Inventory Value 3.1(a) Estimated Closing St. Lucia Working Capital ~~Estimate 2.17(a~~3.1(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Estimated Closing Statement 3.1(a) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time Excluded Assets 2.2 Excluded Liabilities 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(aField Inspector 6.21(a) Final ~~Working Capital 2.17(e~~Purchase Price 3.2(d) ~~Firm 11.9 FTC 6.2(a~~Final Purchase Price Adjustment 3.2(d) ~~Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Hess Foundation Parcel 6.23(b) Indemnified ~~D&Os 6.4(a~~Party 8.6(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 8.6(a) ~~Interim Balance Sheet 3.9(b~~Knowledge of Purchaser 1.5 Knowledge of Seller 1.5 Leftover Product 6.21(c) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter~~ Notice of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities Objection 3.2(b) ~~Survival Date 10.3(a~~Owned Real Property 4.5(a) ~~Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Permits 4.15 Port Reading Decommissioning 6.19

Appears in 1 contract

Sources: Purchase and Sale Agreement (Buckeye Partners, L.P.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement, the following terms ~~shall~~ have the meanings set forth on in the ~~pages of this Agreement~~ sections indicated below: ~~280G Approval 6.3(c~~ACA 4.18(d) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~ADEA 6.9(b) Agreement ~~Preamble Agreement Date Preamble~~ Introduction Allocation ~~Certificate 6.8 Antitrust Filings 6.2(a~~6.6(b) ~~Audited~~ Auditor 6.15 Balance Sheet ~~3.9(b~~4.6(a) ~~Audited Balance Sheet Date 3.9(b~~Basket 8.1(b)(i) ~~Audited Financial Statements 3.9(b~~Benefit Plans 4.18(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4~~ Breach 4.12(f) Buyer Introduction Buyer Documents 5.2 Buyer Indemnified Persons 8.1(a) Cap 8.1(b)(iii) Cash Payment 2.2 Cash Payment Statement 2.5(b)(i) Claims ~~10.4 CLIA 1.1~~ 6.9(a) Claim Notice 8.3 Closing ~~2.4~~ 3.1 Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~3.1 Company Introduction Company Leases 4.14(b) Company-Owned Software 4.17(f) Company ~~Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Indemnified Persons 8.2(a) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Competing Business 6.8(c) ~~Company Preferred Stock 2.10(b~~Covered Area 6.8(c) ~~Company Representative 5.11 Company Software 3.18(l) Company Third~~ Disclosing Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a6.3 DME Business 6.12 EEOC 6.9(e) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~3.1 End Date 9.1(b) ~~Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~ERISA Affiliate 4.18(c) Escrow ~~Agent 2.16~~ Agreement 3.2(a)(ii) Escrow ~~Agreement 2.16~~ Release Amount 2.4 Escrow ~~Fund 2.16~~ Release Date 2.4 ESOP Introduction ESOP Trust Introduction Estimated ~~Working Capital Surplus 2.17(b~~Cash Payment 2.5(a) ~~FDA Requirements 3.19(a~~Estimated Cash Payment Statement 2.5(a) Excluded Assets 2.6 Final ~~Working Capital 2.17(e~~Cash Payment Statement 2.5(b)(iv) ~~Firm 11.9 FTC 6.2(a~~Financial Statements 4.6(a) Fundamental Representations ~~10.2(a)(ii~~8.1(b)(iv) ~~HSR Act 6.2(a~~Illustrative Allocation Schedule 6.6(b) Indemnified ~~D&Os 6.4(a~~Party 8.3 Indemnifying Party 8.3 Independent ESOP Trustee Introduction Leased Real Property 4.14(b) Losses 8.1(a) Malicious Code 4.17(d) Material Contracts 4.16(a) Material Suppliers 4.25(b) Merrell Trust Introduction Neutral Auditor 2.5(b)(iii) Party(ies) Introduction Pay-off Letter 3.2(a)(iii) Principals Introduction Purchase Price 2.2 Released Parties 6.9(a) Releasors 6.9(a) Representation Letter 6.15 Resolution Period 2.5(b)(ii) Restricted Period 6.8(a) S Corporation Election Date 4.9 Seller Documents 4.2 Seller Indemnified ~~Parties 10.1(a~~Persons 8.2(a) ~~Interim Balance Sheet 3.9(b~~Shares Introduction StateServ Note 2.2(h) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Tail Insurance 6.10 Third Party Claim ~~10.4(b~~8.5 Third Party Payor(s) ~~Working Capital Deficit 2.17(f~~4.25(a) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Unresolved Claim 2.4 WARN Act 4.20

Appears in 1 contract

Sources: Stock Purchase Agreement (Addus HomeCare Corp)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Defined Term Section Accounting Principles 3.5(b) ~~280G Payments 6.3(c~~Acquired Business 5.13(b) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Acquired Company Leased Real Property 3.9(b) Acquired Company Real Property 3.9(a) Acquired Business 5.13(b) Acquired Company Real Property 3.9(a) Acquired Company Leased Real Property 3.9(b) Acquired Competing Business 5.13(b) Adjustment Calculation 2.7(b) Adjustment Notice 2.7(b) Affiliate Indemnified Party 5.8(a) Agreement Preamble ~~Agreement Date Preamble~~ Aggregate Cap 8.5(a)(ii) Allocation ~~Certificate 6.8~~ Statement 2.8(a) Ancillary Services 3.7 Antitrust ~~Filings 6.2(a~~Laws 5.3(b) ~~Audited Balance Sheet 3.9(b) Audited~~ Assumed Liabilities 2.4 Balance Sheet Date ~~3.9(b~~3.5(a) ~~Audited Financial Statements 3.9(b~~Bonuses 10.12 Business Information 5.5(b) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Business Registered Intellectual Property 3.10(b) Business Transfer Agreements 2.2 CareFusion Name 5.21(a) CareFusion Name Period 5.21(a) Cash Purchase Price 2.6 CFN 2200 Preamble CFN 303 Preamble Claim Notice 8.3(a) Claim Period 8.4(c) Closing ~~2.4~~ 2.9 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a2.9 Commitment Letters 4.7 Confidential Information 3.10(g) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~5.5(a) ~~Delivered Tax Returns 3.22(a~~Covered Products 5.21(a) ~~DGCL Preamble~~ Disclosure ~~Statement 5.8(a~~Schedule 11.7 Dispute Notice 2.7(c)(ii) ~~Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~ERISA 3.13(e) ~~Effective Time 2.4 Employee Pension Benefit Plan 3.15(h~~Estimated Closing Indebtedness 2.7(a) ~~Employee Plan 3.15(h~~Estimated Closing Net Working Capital 2.7(a) ~~Employee Welfare Benefit Plan 3.15(h~~Estimated Closing Net Working Capital Adjustment 2.7(a) ~~Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16~~ Estimated Closing Net Working Capital Surplus ~~2.17(b~~2.7(a) ~~FDA Requirements 3.19(a~~Excluded Assets 2.3 Excluded Liabilities 2.5 (a) Final Allocation Statement 2.8(a) Final Closing Cash 2.7(b) Final Closing Indebtedness 2.7(b) Final Closing Net Working Capital ~~2.17(e~~2.7(b) ~~Firm 11.9 FTC 6.2(a~~Financial Statements 3.5(a) Fundamental Representations ~~10.2(a)(ii~~8.4(b) ~~HSR Act 6.2(a~~General Name Period 5.21(c) Governmental Antitrust Authority 5.3(a) Included Contracts 2.1(b)(ii) Indemnified ~~D&Os 6.4(a~~Party 8.3(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 8.3(a) ~~Interim Balance Sheet~~ Independent Accounting Firm 2.7(e) IP Assignment 2.10(a)(iv) IP Licenses 3.10(e) Leases 3.9(b) ~~Interim Balance Sheet Date 3.9(b~~Leased Real Property 2.1(b)(iv) ~~Interim Financial Statements 3.9(b~~Material Contracts 3.11(a) InMaterial Governmental Authorizations 3.16(a) Non-~~the~~Solicitation Period 5.14 Post-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(aCovenant 8.4(a) Pre-Closing Adjustment Notice 2.7(a) Protected Employee 5.14 Purchase Price 2.6 Purchased Assets 2.1(b) Purchased Intellectual Property 2.1(b)(v) Purchased Inventory 2.1(b)(i) Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 8.1 Purchaser’s Written Response 2.8(a) Reference Calculation 2.7(a) Required Systems Software 5.18 Relevant Jurisdiction 9.8(b)(i) Reorganization 5.11 Restricted Activities 5.13 Restricted Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a~~5.13 Section 338(h)(10) ~~Preliminary Closing Statement 2.17(a~~Election 9.6(a) ~~Prior Merger Agreement~~ Sellers Preamble ~~Related Agreements 3.5(a~~Seller Disclosure Schedule Article 3 Seller Indemnified Parties 8.2 Seller Retained IP 5.19 Share Transfer 2.10(a)(xiii) ~~Seller Group 11.19 Series D Stock 1.1~~ Share Transfer Documents 2.2 Software Licenses 3.10(f) Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(aCap 8.5(b) Third Party Claim ~~10.4(b~~8.3(b) ~~Working Capital Deficit 2.17(f~~Transferred Employee 10.3 Threshold 8.5(a)(i) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~WARN Act 10.4

Appears in 1 contract

Sources: Share and Asset Purchase Agreement (Natus Medical Inc)

Appears in 1 contract

Sources: Merger Agreement (McAfee, Inc.)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: . 280G Stockholder Approval ~~6.3(c)~~ 6.13 280G ~~Payments 6.3(c~~Waiver 7.2(c) 401(k) Plan 6.13 Action of Divestiture 6.8(a) Actual Cash 2.10(c) Actual Company Debt 2.10(c) Actual Excess Fees 2.10(c) Actual Working Capital 2.10(c) Acquisition Proposal ~~5.11~~ 5.3(a) Acquisition ~~Sub Preamble Agreed Claims 10.4(g~~Transaction 9.3(a)(i) Additional Shares 2.11(a)(i) Affected Stockholders 6.25(a) Agent Indemnification Expenses 8.7(d)(vii) Agent Interpleader Expenses 8.7(d)(vi) Agreement Preamble ~~Agreement~~ Applicable Expiration Date ~~Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~8.1(a) ~~Audited Balance Sheet 3.9(b~~Bylaws 3.1(a) ~~Audited~~ Balance Sheet Date ~~3.9(b~~3.7 Cancellation Fees 6.9(d) ~~Audited Financial Statements 3.9(b~~Cancellation Notices 6.9(d) ~~California Stockholder Approval 3.8~~ Certificate of Incorporation 3.1(a) Certificate of Merger ~~2.4 Claims 10.4 CLIA 1.1~~ 2.3(a) Change of Control Fees 6.9(d) Charter Documents 3.1(a) Claim Certificate 8.5(a) Closing ~~2.4~~ 2.2 Closing Date ~~2.4~~ 2.2 Closing ~~Working Capital Estimate 2.17(a~~Statement Memorandum 2.10(c)(i) Company Preamble Company Authorizations 3.18 Company Board ~~Approval 3.5 Company Certificate 2.10(e)~~ Recommendation 3.4 Company Disclosure Schedule ~~3.0~~ Article III Company ~~Disclosure Schedules 3.0 Company Option 2.13(a~~Expenses 9.3(b)(i) Company ~~Preferred Stock 2.10(b~~Indemnified Parties 6.23(b) Company ~~Representative 5.11 Company Software 3.18(l~~Intellectual Property Contracts 3.14(e)(i) Company ~~Third Party Consents 6.3(b~~Privacy Policy 3.14(m)(i) Company ~~Warrant 2.14(a~~Released Party 6.25(b) Company ~~Warrant Documents 2.12(a~~Releasing Parties 6.25(b) ~~Confidentiality~~ Company Source Code 3.14(l) Company Stockholder Meeting 6.3(a) Company User Data 3.14(m)(i) Company Voting Proposal 3.4 Conflict 3.5 Consent Fees 6.9(a) Continuing Employee Options 6.11(c) Continuing Employee Restricted Stock Units 6.11(d) Copyrights 1.1(ggg) Critical Person Retention Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a~~Recitals Current Balance Sheet 3.7 Deferred Merger Consideration 2.11(a)(i) DGCL ~~Preamble Disclosure Statement 5.8(a~~2.1(a) D&O Policy 6.23(c) Director and Officer Resignation and Release Letter 6.10(b) Dissenting Share Payments 2.8(c) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15~~ 2.8(a) DOJ ~~6.2(a~~6.8(b) Domain Names 1.1(hhh) Earned Employee Restricted Stock Units 6.11(e) EBITDA Shares 2.11(a)(ii) EBITDA Target 2.11(a)(iv) EBITDA Target Floor 2.11(a)(iv) Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~2.3(a) Escrow Agent ~~2.16 Escrow Agreement 2.16~~ Preamble Escrow Fund ~~2.16~~ 8.7(a) Escrow Period 8.7(b) (a) Estimated Closing Statement 2.10(a) Estimated Company Debt 2.10(a) Estimated Excess Fees 2.10(a) Estimated Working Capital ~~Surplus 2.17(b~~2.10(a) ~~FDA Requirements 3.19(a~~Excess Amount 2.9(b)(iv) Excess Fees 6.14 Exchange 6.25(a) Exchange Act 4.9(a) Expiration Date 8.1(a) FCPA 3.24 Final Adjusted Cash Consideration 2.10(b) Final ~~Working Capital 2.17(e~~Surviving Entity 2.1(b) ~~Firm 11.9~~ Financials 3.7 First Step Merger Recitals FTC ~~6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a~~6.8(b) Indemnified Parties ~~10.1(a~~8.2(a) Indemnified Party 8.2(a) Indemnifying Party 8.2(a) Interim ~~Balance Sheet 3.9(b)~~ Financials 3.7 Interim ~~Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b~~Surviving Corporation 2.1(a) In-~~the-Money Company Option 2.13(a~~Licenses 3.14(e)(i) ~~In-the-Money Company Warrant 2.14(a~~Issue Defect 6.25(a) Joint Instruction 8.7(c)(ii) Lease Agreements 3.13(b) Leased Real Property ~~3.14(a~~3.13(a) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Liabilities 3.9 Loss 8.2(a) ~~License Agreement 3.16(a)(xi~~Losses 8.2(a) ~~License Agreements 3.16(a)(xi~~Material Contract 3.16(a) ~~Majority Effective Time Holders 9.1(c~~Material Contracts 3.16(a) ~~Measurement Date 1.1~~ Maximum Aggregate Premium 6.23(c) Merger Recitals Merger Subs Preamble ~~Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent~~ Merger Sub One Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger ~~Agreement~~ Sub Two Preamble ~~Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii~~Modification Fees 6.9(b) ▇▇▇▇▇’▇ ~~Law 3.12(b~~8.7(c)(ii) ~~Stockholder Approval 3.8~~ Non-U.S. Benefit Plan 3.22(e) Notice of Dispute 2.10(d) Objection Notice 8.5(b) Open Source Material 3.14(k) Option Consideration 2.9(b)(vi) Optionholder’s Portion of the Merger Consideration 2.9(b)(vi) Out-Licenses 3.14(e)(i) Parent Preamble Parent Board Recommendation 4.2 Parent Disclosure Schedule Article IV Parent Expenses 9.3(a)(iv) Parent Plans 6.11(b) Parent Principal Stockholders Recitals Parent Stockholder Meeting ~~5.8(b~~6.2(a) ~~Straddle~~ Parent Stockholder Voting Agreement Recitals Parent Voting Proposal 4.2 Patents 1.1(ggg) Performance Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f2.11(a)(vi)

Appears in 1 contract

Sources: Merger Agreement (Limelight Networks, Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~10 Acquired Company Leased Real Property 3.8(b) ~~280G Payments 6.3(c~~Acquired Company Real Property 3.8(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Calculation 2.7(a) Adjustment Notice 2.7(a) Agreement Preamble ~~Agreement Date Preamble~~ Allocation ~~Certificate 6.8~~ Statement 2.8(a) Alternative Transaction 5.14 Antitrust ~~Filings 6.2(a~~Laws 5.3(b) ~~Audited~~ Assumed Benefit Plans 10.3 Assumed Liabilities 2.3 Balance Sheet ~~3.9(b~~3.5(a) ~~Audited~~ Books and Records 2.1(b) Business Information 5.6(b) Casualty Loss 5.11(b) China Formation Requirements 5.19 Claim Notice 8.3(a) Closing 2.9 Closing Balance Sheet 2.7(a) Closing Date ~~3.9(b~~2.9 Closing Net Cash Statement 2.7(a) ~~Audited~~ Closing Net Working Capital Statement 2.7(a) Closing Receivables 5.15 Commitment Letter 4.7 Confidentiality Agreement 5.6(a) Covenant IP 5.3(a) Credit Support Obligations 5.16 Deductible 8.5(a) Dispute Notice 2.7(b) Economic Sanctions 3.16(c) Employee Matters Agreement 2.1(d) (a) Estimated Closing Net Cash 2.6 (a) Estimated Closing Net Working Capital 2.6(a) Excluded Assets 2.2 Excluded Liabilities 2.4 Final Closing Net Cash 2.7(f) Final Closing Net Working Capital 2.7(f) Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a3.5(a) Fundamental Representations ~~10.2(a)(ii~~and Warranties 8.4(a) German Sale and Transfer Agreement 2.1(e) Governmental Antitrust Authority 5.3(b) 11 Guarantee 11.18(a) HSR Act ~~6.2(a~~5.3(b) Included Contracts 2.1(b) Indemnified ~~D&Os 6.4(a~~Party 8.3(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 8.3(a) Independent Accounting Firm 2.7(e) Insurance Policies 3.18 Interim Balance Sheet ~~3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~3.5(a) Leased Real Property ~~3.14(a~~2.1(b) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Lender 4.7 Local Transfer Agreements 2.1(c) ~~License Agreement 3.16(a)(xi~~Material Contracts 3.10(a) ~~License Agreements 3.16(a)(xi~~Obligations 11.18(a) ~~Majority Effective Time Holders 9.1(c~~OFAC 3.16(c) ~~Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c~~Owned Real Property 2.1(b) ~~Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent~~ Phase I Closing 2.9 Phase I Closing Balance Sheet ~~2.17(c~~2.7(a) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent~~ Phase I Closing Net Working Capital Statement ~~2.17(c~~2.7(a) ~~Paying Agent 2.11(a~~Phase I Closing Date 2.9 Phase I Outside Date 7.1(c) ~~Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-~~Phase II Closing ~~Period 6.1 Preliminary~~ 2.9 Phase II Closing Balance Sheet ~~2.17(a~~2.7(a) ~~Preliminary~~ Phase II Closing ~~Statement 2.17(a~~Date 2.9 Phase II Letter of Credit 2.10(b) ~~Prior Merger~~ Phase II Outside Date 7.2(c) Purchase Price 2.5 Purchase Price Reduction 2.13 Purchased Assets 2.1(b) Purchased Intellectual Property 2.1(b) Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 8.1 Purchaser Supply Agreement ~~Preamble Related Agreements 3.5(a~~2.10(a) Restrictive Covenant Agreement 2.10(a) Resolution Period 2.7(e) Revised Deductible 8.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(fPreamble Seller Disclosure Schedule Article 3 Seller Indemnified Parties 8.2 Seller Signage 5.17 Seller Supply Agreement 2.10(a)

Appears in 1 contract

Sources: Share and Asset Purchase Agreement (Brady Corp)

Appears in 1 contract

Sources: Agreement and Plan of Merger (Nuance Communications, Inc.)

Appears in 1 contract

Sources: Merger Agreement (Athenex, Inc.)

Appears in 1 contract

Sources: Merger Agreement (Alkami Technology, Inc.)

Additional Defined Terms. ~~The~~ For purposes of this Agreement, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Abandonment Notice 2.7(b)(v) ~~280G~~ Accounting Firm 2.9(c) Acquired Business 5.15(a)(ii) Acquired Competing Business 5.15(a)(ii) Acquired Contracts Exhibit B Adjusted Net Transfer Amount 7.3(a)(ii) Agreed Assumptions 1.1 Assigned Intellectual Property Exhibit B Alternate Transaction 5.14 AndroGel Milestone Payments ~~6.3(c~~2.6(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~AndroGel Net Sales Records 2.6(d) ~~Agreement Preamble Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~Arbitral Tribunal Schedule 12.10 Arbitration Schedule 12.10 Assets 7.2(e) (a) Audited ~~Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited~~ Non-Consolidated Financial Statements ~~3.9(b~~3.6(c) ~~California Stockholder Approval 3.8 Certificate~~ Business Intellectual Property 3.13(a) Buyer Parent Preamble Buyer Parent Field of ~~Merger 2.4 Claims 10.4 CLIA 1.1~~ Use 2.12(a) Buyers Preamble Buyers Indemnified Parties 11.1(a) Buyers Benefit Plan 7.9(a) Buyers Dedicated Employees 5.11(b) Buyers Non-Business Pension Indemnification Amount 7.2(f) Buyers Pension Indemnification Amount 7.2(e) (a) Buyer’s U.K Pension Plan 7.4(a) Cap 11.1(b)(i) Certain Nations 3.21(c) Change of Control Payments 3.17(f) Closing ~~2.4~~ 2.7(a) Closing Date ~~2.4~~ 2.7(a) Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Net Working Capital Statement ~~2.17(c~~2.9(a) ~~Paying Agent 2.11(a~~Commercially Reasonable Efforts 2.6(c) ~~Paying Agent Agreement 2.11(a~~Commonly Controlled Entity 3.18(a) ~~Payment Fund 2.11(a~~Competing Business 5.15(a) ~~Pre-~~Competition Law Filings 5.3(b) Confidential Information 12.3 Days 1.3 DC Transfer Amount 7.5(b) DC Employees 7.5(a) Deductible 11.1(b)(i) Deferred Local Business 2.7(b)(i)(A)(1) Deferred Local Closing ~~Period 6.1 Preliminary~~ 2.7(b)(ii) Deminimis Amount 11.1(b)(i) Dollars 1.3 Employee Procedures 5.11(a) Environmental Remediation Costs 11.1(b)(iv) Estimated Net Cash 2.5(c) European Bank Facility 5.6(a) Euros 1.3 Fair Market Value 7.2(e) Final Determination Date 7.3(a) Final Statement of Closing ~~Balance Sheet 2.17(a~~Net Working Capital 2.9(d) ~~Preliminary Closing~~ Final Statement ~~2.17(a~~of Net Cash 2.9(e) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Final Transfer Amount 7.3(a) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii~~First Pension Transfer Amount 7.3(a) ▇▇▇▇▇▇▇▇ ~~Law 3.12(b~~5.21(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Government Officials 3.21(a)(i) ICC Rules Schedule 12.10 India Mandatory Takeover Offer 5.20 Initial Purchase Price 2.5(a) Insurance Proceedings 5.17(d) Intercompany Loans 5.5(a) ▇▇▇▇▇▇▇▇ Indemnification 11.1(a)(iv) ▇▇▇▇▇▇▇▇ Release 5.29 Licensed Patents 3.13(a)(ii) Material Contracts 3.14(a) Milestone Due Date 2.6(b) Milestone Report 2.6(b) Mixed Account 5.19(b) (a) Net Cash Statement 2.9(a) Net Transfer Amount 7.3(a)(i) Non-Business Pension Liabilities 7.2(f) Non-Business Transferred Amounts 7.2(f) Non-Final Injunction 2.7(b)(i)(B)(1) Non-Pharma Loans 5.5(a) Non-U.S. Business Employee 7.1 Non-U.S. Buyer DC Plans 7.5(a) Non-U.S. Buyer Pension Plans 7.4(a) Non-U.S. Former Employee 1.1 Non-U.S. Seller DC Plans 7.5(a) Non-U.S. Transferred Employee 7.1 Objection 2.9(b) Owned Patents 3.13(a)(i) Party or Parties Preamble Pension Plan Employees 7.4(a) Pension Plan Former Employees 7.4(a) Pension Transfer Amounts 7.3(a) and 7.4(b) Pharma Health Field of Use 2.12(a) Post-Closing Straddle Period ~~1.1 Subsidiary Securities 3.2(b~~11.10(c) ~~Survival~~ Pre-Closing Straddle Period 11.10(a) Purchase Price 2.5(a) Related Party Contracts 3.19(a) Registered Trademarks 3.13(a)(iii) Response 2.9(c) Restricted Period 5.15(a) Section 75 Debt 7.4(h) Seller Non-U.S. Benefit Plans 3.18(a) Seller U.S. Benefit Plans 3.18(c) Seller Parent Preamble Seller Parent Share of AndroGel Litigation Costs 2.6(e) Seller Parent Representations Article 3 Seller Pension Plans 7.4(a) Sellers Preamble Sellers Dedicated Employees 5.11(b) Sellers Indemnified Parties 11.2(a) Sellers Non-Business Pension Indemnification Amount 7.2(f) Sellers Pension Indemnification Amount 7.2(e) Shares Recitals SIP 7.2(g) Sodufa Recitals Sodufa Shares Recitals Sold Company Pension Plan 7.4(a) Solvay Pharmaceuticals Belgium Recitals Solvay Pharmaceuticals Belgium Employees 7.1 Special Indemnification Matters 11.1(a)(iii) SPML Recitals SPML Shares Recitals Straddle Period 6.2 Takeover Documents 5.20 Tax Claim 11.11(a) Terlin Recitals Termination Date ~~10.3(a~~10.1(b) Transferred U.S. Plans 3.18(d) Thai Business Restructuring 2.1(c) Third Party Claim ~~10.4(b~~11.3(b) ~~Working Capital Deficit 2.17(f~~Third Party Financial Indebtedness 5.6(a) ~~Working Capital Objection Period 2.17(e~~Trailing Benefit Payments 7.3(a)(iii) ~~Working Capital Objection Statement 2.17(e~~Transfer Credits 7.4(a) ~~Working Capital Surplus 2.17(f~~Transferred Employee 7.1 Transferred Amounts 7.2(e) Transition Services Agreement 5.16 Unconsolidated Sold Companies 3.6(c) Unaudited Financial Statements 3.6(a) U.S Business Employee 7.1 U.S. Buyer DC Plans 7.3(b) U.S. Former Employee 1.1 U.S. Transferred Employee 7.1 Voluntary Guidance 3.21(a)(ii) WARN Act 3.17(e)

Appears in 1 contract

Sources: Stock and Asset Purchase Agreement (Abbott Laboratories)

Additional Defined Terms. ~~The~~ For purposes of the Transaction Documents, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Defined Term Section Acquired Assets 2.1(a) ~~280G Payments 6.3(c~~Acquired Intellectual Property 2.1(a)(iv) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Additional Asset 2.8(b) Agreement Preamble Agreement Date Preamble Allocation ~~Certificate 6.8 Antitrust Filings 6.2(a~~Statement 2.7(a) ~~Audited Balance Sheet 3.9(b~~Acquisition Proposal 5.17 Assumed Contracts 2.1(a)(iv) ~~Audited Balance Sheet Date 3.9(b~~Assumed Liabilities 2.1(c)(i) ~~Audited Financial Statements 3.9(b~~Assumption Agreement 2.6(b) ~~California Stockholder Approval 3.8 Certificate~~ ▇▇▇▇ of ~~Merger 2.4~~ Sale 2.6(a) Business Recitals Business Employees 3.11 Claim 8.5(a) Claims ~~10.4 CLIA 1.1~~ Period 8.5(b) Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Payment 2.2 Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~5.12(a) ~~Delivered Tax Returns 3.22(a~~Contested Claim 8.8(b) ~~DGCL Preamble Disclosure Statement 5.8(a~~Contributor 3.8(d) ~~Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h~~Current Asset Schedule 3.10 Customer Consents 5.16 Excluded Assets 2.1(b) Employee ~~Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f~~Liabilities 5.9(b) Escrow Agent ~~2.16~~ 2.5 Escrow Account 2.5 Escrow Agreement ~~2.16~~ 2.5 Escrow Fund ~~2.16 Estimated Working Capital Surplus 2.17(b~~8.1 Equipment 2.1(a)(iii) ~~FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~ESS Process 3.9 Excluded Liabilities 2.1(c)(ii) Fundamental Representations ~~10.2(a)(ii~~8.2 Indemnifiable Damages 8.3 Indemnified Person 8.3 Indemnified Persons 8.3 Indemnity Threshold 8.3 Insurance Policy 3.19 Material Contracts 3.16 Military Printer Business 5.5 Notice of Claim 8.5(a) ~~HSR Act 6.2(a~~Open Source Materials 3.8(i) ~~Indemnified D&Os 6.4(a~~Party Preamble Property 3.13(a)(iv) ~~Indemnified Parties 10.1(a~~Purchase Price 2.2 Purchaser Preamble Restricted Area 5.5 Restricted Business 5.5 Restricted Period 5.5 RITEC Name 5.15(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing RITEC Name Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a~~5.15(a) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Preamble Seller Authorizations 3.4(b) ~~Specified Representations 10.2(a)(iii~~Seller Disclosure Letter Article III Seller Representative 9.11 Straddle Periods 5.10(b) ~~▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third~~ Third-Party Claim ~~10.4(b~~8.5(a)(ii) ~~Working Capital Deficit 2.17(f~~Transaction Recitals Transaction Taxes 5.10(a) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~TSA End Date 5.16

Appears in 1 contract

Sources: Asset Purchase Agreement (Astro Med Inc /New/)

Appears in 1 contract

Sources: Stockholders’ Agreement (F45 Training Holdings Inc.)

Appears in 1 contract

Sources: Stockholders' Agreement (F45 Training Holdings Inc.)

Appears in 1 contract

Sources: Purchase and Sale Agreement (Harvest Natural Resources, Inc.)

Additional Defined Terms. ~~The~~ As used herein the following terms shall have the meanings set forth on in the ~~pages of this Agreement~~ preamble, recital or section indicated below: ~~280G Approval 6.3(c~~$10B HCREIT 2.3 15% Calculation 6.1(iii) ~~280G Payments 6.3(c~~2008 Letter Agreement Recital A 2009 Letter Agreement Recital A 7% Capped Calculation 6.1(iv) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~AAA 15.1(a) Accrued But Not Yet Due Fees and Expenses Reimbursements 18.3 Affected Management Agreement 7.1(d) Aggregate Cure Limit 3.5(a) Aggregate Expense Overage 3.4 Aggregate Expense Overage Amount 3.4 Aggregate Expense Overage Cure 3.4 Aggregate Expense Termination Right 3.4 Agreement Preamble Agreement Date Preamble ~~Allocation Certificate 6.8 Antitrust Filings 6.2(a~~All Facilities Actual Percentage 7.2.3(b) ~~Audited Balance Sheet 3.9(b~~ANOI Testing Date 3.1.1 Applicable BMF Percentage 5.2 Applicable Lenders 18.4 Applicable Period 7.2.3(b) ~~Audited Balance Sheet~~ Arbitrable Dispute 15.1(a) Arbitration Notice 15.1(a) Beneficiaries 16.1 BMF Continuing Facility Adjustment Factor 7.2.3(a) BMF/IMF Continuing Facility Percentage 7.2.3(a) BMF Transferred Facility Adjustment Factor 7.2.3(a) BMF/IMF Transferred Facility Percentage 7.2.3(a) Canadian Budget Percentage 3.4.1(a) Continuing Facilities 7.2.1(a) Continuing Facility Actual Percentage 7.2.3(b) Event of Default 15.1 Existing Facilities Recital B Existing Immediate or Unmatured Event of Default 18.5(a) Existing Loan Document 18.4 Existing Management Agreement Recital C Existing Master Agreement Recital A Existing Owners Recital B Existing Ventas/Sunrise Agreements 18.2 Expense Termination Right 3.4 Facility Cessation Date ~~3.9(b~~7.2 Facility Cure Limit 3.2.2 Facility Expense Overage Cure 3.3 Facility Expense Termination Right 3.3 Facility Performance Cure Amount 3.4(ii) ~~Audited Financial Statements 3.9(b~~IMF Continuing Facility Adjustment Factor 7.2.3(a) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(aIMF Transferred Facility Adjustment Factor 7.2.3(a) Letter ~~Amendment Premable Letter of Transmittal 2.12(a~~Agreements Recital A Management Group 18.3 Monetary Failure Notice 15.1(a) ~~License Agreement 3.16(a)(xi) License~~ New Facilities Recital D New Management Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Recital D New PSF Owners Recital E New Pre-~~Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a~~Stabilized Facility Recital E New SF Owners Recital E New Stabilized Facility Recital E Other Section 3.2.3 Termination Rights 3.2.3(iii) ~~Preliminary Closing Statement 2.17(a~~Payment/Credit-Back 15.1(a) ~~Prior Merger~~ Property Performance Cure 3.2 Property Performance Termination Right 3.1 REIT 14 Related Agreement ~~Preamble~~ SSLI Event of Default/ Termination Right 18.4 Related Agreements ~~3.5(a~~18.3 Released Matters 18.4 Residents 2.1(b) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Restated Management Agreement Recital C SEC 18.5(c) ~~Specified Representations 10.2(a)(iii~~Section 2.3 Person 2.3 Section 3.2.3 Month 3.2.3 Section 3.2.3 Period 3.2.3(i) ~~▇▇▇▇▇ Law 3.12(b~~Section 3.2.3 Termination Right 3.2.3 Section 3.2.3 Waiver 3.2.3 Severed Master Agreement 7.2.2(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Shared Expenses Continuing Facilities Factor 7.2.3(b) ~~Straddle~~ Shared Expenses Percentage 4 Shared Expenses Transferred Facilities Factor 7.2.3(b) Significant Actual Prejudice 18.5(a) SOX 2.5 SSLI Preamble Successor Owner/Lessee 7.1(b) Successor Parent Owner/Lessee 7.1(c) Sunrise Parties 2.3 Terminated Facility 5.5 Terminated Management Agreement 5.5 Termination Effective Date 5.5 Total Facility Overage Payments Amount 3.4(i) Total Performance Cure Amount 3.4(ii) Trailing Twelve Month Period ~~1.1 Subsidiary Securities 3.2(b~~7.2.3(a) ~~Survival Date 10.3(a~~Transferred Facility 7.1(a) ~~Third Party Claim 10.4(b) Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Transferred Facilities 7.1(c)

Appears in 1 contract

Sources: Master Agreement (Sunrise Senior Living Inc)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Adjustment Calculation 2.7(a) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Notice 2.7(a) Agreement Preamble Annual Earn-out Payment 2.8(d) Annual Earn-out Period 2.8(a) Arbitrating Accountant 2.9(a) Assignment and Assumption Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.12(a) ~~Audited~~ Associate 3.26 Assumed Liabilities 2.3 Balance Sheet ~~3.9(b~~3.5(a) ~~Audited~~ B▇▇▇ of Sale 2.12(a) Claim Notice 9.3(a) Closing Balance Sheet ~~Date 3.9(b~~2.7(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a2.11 COBRA 8.13(d) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~8.4(a) ~~Delivered Tax Returns 3.22(a~~Controlling Party 9.4(c) ~~DGCL Preamble Disclosure Statement 5.8(a~~Dispute Notice 2.7(b) ~~Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~Earn-out Calculation 2.8(a) ~~Effective Time 2.4 Employee Pension Benefit Plan 3.15(h~~Economically Neutral 2.13(b) ~~Employee Plan 3.15(h~~Employment Agreements 2.12(a) ~~Employee Welfare Benefit Plan 3.15(h~~Estimated Closing Balance Sheet 2.6(a) ~~Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16~~ Estimated Closing Net Working Capital ~~Surplus 2.17(b~~2.6(a) ~~FDA Requirements 3.19(a)~~ Excluded Assets 2.2 Excluded Liabilities 2.4 Final Closing Net Working Capital ~~2.17(e~~2.7(a) ~~Firm 11.9 FTC 6.2(a~~Financial Statements 3.5(a) ~~Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Hired Employee 8.13(a) Indemnified ~~D&Os 6.4(a~~Party 9.3(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 9.3(a) Initial Purchase Price 2.5 Interim Balance Sheet ~~3.9(b~~3.5(a) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~IP Assignments 2.12(a) Leased Real Property ~~3.14(a~~3.12(b) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Noncontrolling Party 9.4(c) ~~License Agreement 3.16(a)(xi~~Objection Notice 9.3(b) ~~License Agreements 3.16(a)(xi~~Owned Intellectual Property 3.13(a) ~~Majority Effective Time Holders 9.1(c~~Purchase Price 2.5 Purchased Assets 2.1 Purchased Intellectual Property 2.1 Purchaser Preamble Purchaser Indemnified Parties 9.1 Qualifying Gross Margin Dollars Schedule 2.8(g) ~~Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c~~Qualified Plan 3.16(e) ~~Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b~~Restrictive Period 8.8(d) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(aRestricted Persons 8.4(b) Seller ~~Group 11.19 Series D Stock 1.1~~ Preamble Seller Disclosure Schedule Article 3 Selling Parties’ Representative 10.1 Shareholders Preamble Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(aClaim 9.4(b) Third Party Claim ~~10.4(b~~9.4(a) ~~Working Capital Deficit 2.17(f~~Third Party Intellectual Property 3.13(c) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Transfer Taxes 8.1(a)

Appears in 1 contract

Sources: Asset Purchase Agreement (Fuel Tech, Inc.)

Additional Defined Terms. The following capitalized terms shall have the respective meanings set forth on in the ~~pages~~ respective Sections of this Agreement ~~indicated~~ set forth opposite each such respective term below: ~~280G Approval 6.3(c) 280G Payments 6.3(c)~~ Acquisition ~~Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Transactions Recitals Agreement Preamble ~~Agreement Date~~ Allocation 1.7 Asset Purchase Recitals Assignment Instruments 5.2(j) Assumed Liabilities 1.4(a) Background License 4.6 Basket Amount 6.3(b) Books and Records 1.3(c) Business Authorizations 2.13 Buyer IP Preamble ~~Allocation~~ Buyer Parent Preamble Buyer Parties Preamble Buyer R&D Preamble Buyer Secretary Certificate ~~6.8 Antitrust Filings 6.2(a~~5.3(e) ~~Audited Balance Sheet 3.9(b) Audited Balance Sheet Date 3.9(b) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate~~ Capital Stock 4.7 Change of ~~Merger 2.4 Claims 10.4 CLIA 1.1~~ Control 4.7 Charter Documents 2.1 Closing ~~2.4~~ 1.5 Closing Date ~~2.4 Closing Working Capital Estimate~~ 1.5 COBRA 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap~~ 4.2 Conflict 2.5 Consultant Proprietary Information Agreement 2.10(x) Contract(s) 2.5 Copyright Co-Ownership Recitals Copyright Co-Ownership Agreement 5.2(d) Copyrights 1.1 Counsel 4.1(b) Disclosure Schedule Article II DOL 2.17(a) Employee Agreement 2.17(a) Employee Proprietary Information Agreement 2.10(x) ERISA 2.17(a) ERISA Affiliate 2.17(a) Escrow Agreement 6.4(a) Escrow Amount 6.4(a) Escrow Fund 6.4(a) Escrow Period 6.4(b) ~~Delivered Tax Returns 3.22(a~~Exercise Notice 4.7 Exercise Period 4.7 FMLA 2.17(a) ~~DGCL Preamble Disclosure Statement 5.8(a~~HIPAA 2.17(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(aInbound-Licenses 2.10(o) Indemnified Parties ~~10.1(a~~6.2(a) ~~Interim Balance Sheet 3.9(b~~Intercompany-Licenses 2.10(o) ~~Interim Balance Sheet Date 3.9(b~~International Employee Plan 2.17(a) ~~Interim Financial Statements 3.9(b~~IP Contracts 2.10(p) (a) ~~In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~Lease Agreements 2.9(a) Leased Real Property ~~3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a~~2.9(a) License Recitals License Agreement ~~3.16(a)(xi~~5.2(c) ~~License Agreements 3.16(a)(xi~~Loss(es) ~~Majority Effective Time Holders 9.1(c~~6.2(a) ~~Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c~~NDAs 2.10(o) ~~Organizational Documents 3.3 Out~~Non-ofPaying Party 4.5(b)(iii) Offered Assets 4.7 Officer’s Certificate 6.4(a) Outbound-~~the-Money Company Option 2.13(b~~Licenses 2.10(o) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) P▇▇▇▇▇ ~~Law 3.12(b~~Employment Agreement Recitals Patents 1.1 Paying Party 4.5(b)(iii) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~PBGC 2.17(a) Pension Plan 2.17(a) P▇▇▇▇▇▇ Employment Agreement Recitals PTO 1.1 Purchase Price 1.6(a) Purchased Assets 1.3 Referral Agreement 5.2(f) Referral Services Recitals Retained Liabilities 1.4(b) Returns 2.7(b)(i) Right of First Refusal 4.7 Rohm & H▇▇▇ Amendment 5.2(i) Seller Employee Plan 2.17(a) Seller IP Preamble Seller Parent Preamble Seller Parties Preamble Seller R&D Preamble Seller Secretary Certificate 5.2(h) Straddle Period ~~1.1 Subsidiary Securities 3.2(b~~Tax 4.5(b)(iii) Survival Date ~~10.3(a~~6.1 Tax(es) 2.7(a) Third Party Claim ~~10.4(b~~6.4(c) ~~Working Capital Deficit 2.17(f~~Third Party Expenses 4.3 Trade Secrets 1.1 Trademarks 1.1 Transfer Notice 4.7 Transfer Taxes 4.5(a) ~~Working Capital Objection Period 2.17(e~~Transferred Employees 1.4(c) ~~Working Capital Objection Statement 2.17(e~~Transition Services Recitals Transition Services Agreement 5.2(e) ~~Working Capital Surplus 2.17(f)~~Voting Stock 4.7

Appears in 1 contract

Sources: Asset Purchase Agreement (Rambus Inc)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Transaction Documents, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g)~~ Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited~~ Algeria Cash Consideration 2.4 Asset Transfer Agreements 2.3 Balance Sheet ~~3.9(b~~3.6(a)(ii) ~~Audited~~ Balance Sheet Date ~~3.9(b~~3.6(a)(ii) ~~Audited Financial Statements 3.9(b~~Bankruptcy and Equity Exception 3.2(a) ~~California Stockholder Approval 3.8 Certificate of Merger~~ Business Intellectual Property 3.10 Business Leased Real Property 3.9(a) Cash Consideration 2.4 ~~Claims 10.4 CLIA 1.1~~ Claim Notice 8.3(a) Closing ~~2.4~~ 2.7(a) 428928/HOUDMS Closing Date ~~2.4~~ 2.7(a) Closing ~~Working Capital Estimate 2.17(a~~Time 2.7(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Controlling Party 8.3(d) ~~Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Deductible 8.5(a) ~~Company Preferred Stock 2.10(b~~Deposit 2.4(a) ~~Company Representative 5.11 Company Software 3.18(l~~Dispute Notice 2.5(b) ~~Company Third Party Consents 6.3(b~~Dispute Representatives 11.11(a) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(fEmployees List 3.13(a) Escrow Agent ~~2.16~~ 2.4(a) Escrow Agreement ~~2.16 Escrow Fund 2.16 Estimated~~ 2.4(a) Excluded Liabilities 2.2 Final Allocation 2.6 Final Closing Net Cash 2.5(c) Final Closing Net Working Capital ~~Surplus 2.17(b~~2.5(c) ~~FDA Requirements 3.19(a~~Financial Statements 3.6(a) ~~Final~~ Financing Commitments 4.7 ICC 11.11(b) Indemnified Party 8.3(a) Indemnifying Party 8.3(a) Independent Accounting Firm 2.5(c) Independent Contractors List 3.13(a) Initial Closing 2.7(b) Initial Closing Date 2.7(b) Initial End Date 7.1(f) KOC 5.16 Kuwait Cash Consideration 2.4 Net Working Capital ~~2.17(e~~and Net Cash Calculation 2.5(a) ~~Firm 11.9 FTC 6.2(a~~Non-controlling Party 8.3(d) ~~Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a)~~ Party Preamble PD Cyprus/Joint Venture Indemnified ~~D&Os 6.4(a)~~ Party Section 5.8 Purchase Price 2.4 Purchaser Preamble Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties ~~10.1(a~~8.1 Recipient 9.3(a) ~~Interim Balance Sheet 3.9(b~~Relevant Amount Section 5.11 Restructuring 5.15 Restructuring Plan 5.15 Rig Capital Expenditure Program 5.2(b) ~~Interim Balance Sheet~~ Rules 11.11(b) Seller Preamble Seller Disclosure Schedule Article 3 Seller Guarantees Section 5.11 Seller Indemnified Parties 8.2 Subsequent Closing 2.7(b) Subsequent Closing Date ~~3.9(b~~2.7(b) ~~Interim Financial Statements 3.9(b~~Subsequent End Date 7.1(i) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Target Net Working Capital ~~Determination 2.17(c~~Amount 2.5(d) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(aTeam Source 3.13(a) Third Party Claim ~~10.4(b~~8.3(b) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Transfer Agreements 2.3 428928/HOUDMS

Appears in 1 contract

Sources: Sale and Purchase Agreement (Weatherford International PLC)

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~AAP Assets 2.6(a) ~~280G Payments 6.3(c~~Adjustment Calculation 2.4(a) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Notice 2.4(a) ~~Agreement~~ AGIP First Paragraph AGIP Sellers Preamble Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a) Audited~~ First Paragraph Balance Sheet ~~3.9(b~~3.5(a) ~~Audited~~ Cap 7.6(a) Certain Nations 3.19(f) Claim Amount 7.6(a) Claim Notice 7.3(a) Class A Shares 3.4(a) Class B Shares 3.4(a) Closing 2.5 Closing Balance Sheet ~~Date 3.9(b~~2.4(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~2.5 Company First Paragraph Company Intellectual Property 3.12(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Competing Activity 5.3(a) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(aConfidential Information 5.2(a) Confidentiality Agreement ~~5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~5.2(a) ~~Delivered Tax Returns 3.22(a~~Controlling Party 7.4(f) ~~DGCL~~ Convertible Debt Assignment and Transfer Documents 2.6(a) Covered Claims Schedule G Disputed Amount 7.7(c) Dispute Notice 2.4(b) [***] = Confidential Treatment requested for redacted portion; redacted portion has been filed separately with the Commission. Earnout Amount Schedule C Earnout Participants Schedule C Employee IP Assignment and Release Agreements 2.6(a) Employment Agreements 2.6(a) Equity Interests Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(fEquity Transfer Documents 2.6(a) Escrow Agent ~~2.16~~ 2.6(a) Escrow Agreement ~~2.16~~ 2.6(a) Escrow Amount 2.6(c) Escrow Fund ~~2.16~~ 2.7 Estimated ~~Working Capital Surplus 2.17(b~~Closing Balance Sheet 2.3 [***] 2.4(a) ~~FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a~~Financial Statements 3.5(a) Indemnified ~~D&Os 6.4(a~~Party 7.3(a) ~~Indemnified Parties 10.1(a~~Indemnifying Party 7.3(a) Indemnity Determination Date 7.3(h) Indemnity Final Determination 7.3(h) Indemnity Interest Amount 7.7(b) Independent Accounting Firm 2.4(d) Initial Purchase Price 2.2 Interim Balance Sheet ~~3.9(b~~3.5(a) ~~Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a~~Key Employees 3.9(j) Leased Real Property ~~3.14(a~~3.11(b) ~~Letter Amendment Premable Letter of Transmittal 2.12(a~~Membership Interests Preamble Non-Controlling Party 7.4(f) ~~License Agreement 3.16(a)(xi~~Objection Notice 7.3(b) ~~License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble~~ Option Cancellation ~~Agreement 2.13(c~~Agreements 2.6(a) ~~Organizational~~ Option Share Transfer Documents ~~3.3 Out-of-the-Money Company~~ 2.6(a) (a) Parity Option ~~2.13(b~~Assignment and Transfer Documents 2.6(a) ~~Out-of-the-Money Company Warrant 2.14(b~~Performance Share Unit Agreements 2.6(a) ~~Outside~~ Purchase Price 2.2 Priceline US First Paragraph Pro Rata Portion Schedule C Purchasers First Paragraph Purchaser Disclosure Schedule Article 4 Purchaser Indemnified Parties 7.1 Released Earnout Amount 7.7(c) Restricted Stock Unit Agreements 2.6(a) Scheduled Earnout Payment Date ~~8.1(b~~7.7(c) ~~Parent Preamble Parent Closing Balance Sheet 2.17(c~~Securities Act 3.4(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(aSellers First Paragraph Seller Disclosure Schedule Article 3 Seller Releases 2.6(a) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Representative 8.1(a) ~~Specified Representations 10.2(a)(iii~~Shares Preamble Share Purchaser First Paragraph Share Sellers Preamble Share Transfer Forms 2.6(a) ~~▇▇▇▇▇ Law 3.12(b~~Third-Party Claim 7.4(a) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Third-Party Claim Notice 7.4(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a)~~ [***] = Confidential Treatment requested for redacted portion; redacted portion has been filed separately with the Commission. Third Party ~~Claim 10.4(b~~Intellectual Property 3.12(c) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Threshold 7.6(a)

Appears in 1 contract

Sources: Equity Purchase Agreement (Priceline Com Inc)

Additional Defined Terms. ~~The~~ In addition, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: 280G ~~Approval 6.3(c)~~ Disclosure 5.4 280G Payments ~~6.3(c~~5.4 280G Stockholder Vote 5.4 ABC Consulting 2.10(f) ~~Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~ABC Notes 1.1 Administrative Costs 11.19(a) Agreement Preamble ~~Agreement Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a)~~ Assumptions 4.6 Audited Balance ~~Sheet 3.9(b) Audited~~ Sheets 3.5 Balance Sheet Date ~~3.9(b~~3.5 Base Consideration 2.2 Business Systems 3.14(d) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8~~ Buyer Preamble Buyer Parties Preamble Certificate of Merger ~~2.4~~ 2.3 Chosen Courts 11.7 Claims ~~10.4 CLIA 1.1~~ 6.4(d) Closing ~~2.4~~ 2.9(a) Closing Date ~~2.4~~ 2.9(a) Closing ~~Working Capital Estimate 2.17(a~~Option Consideration 2.7(c)(i) Closing Payment Spreadsheet 2.8(b) Closing RSU Consideration 2.7(c)(iii) Closing Statement 2.10(a) Company Preamble Company ~~Board Approval 3.5 Company Certificate 2.10(e~~Employees 6.6(a) Company ~~Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a~~Intellectual Property Assets 3.14(d) Company ~~Preferred Stock 2.10(b~~Subsidiary 3.3 Company Transaction Expense Amount 2.2(g) ~~Company Representative 5.11 Company Software 3.18(l~~Contracting Party 11.15 Copyrights 3.14(d)(iii) ~~Company Third Party Consents 6.3(b~~D&O Indemnified Parties 6.4(a) ~~Company Warrant 2.14(a~~Data Security Laws 3.14(d) ~~Company Warrant Documents 2.12(a~~Debt Financing 6.12 Debt Payoff Amount 2.8(a) ~~Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b~~Disputed Items 2.10(c) ~~Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a~~Dissenting Holders 2.7(b)(iii) Dissenting Shares ~~2.15 Dissenting Stockholders 2.15 DOJ 6.2(a~~2.7(b)(iii) DGCL Recitals Effective Time ~~2.4 Employee Pension Benefit Plan 3.15(h~~2.3 End Date 10.1(b) ~~Employee Plan 3.15(h~~ERISA 3.11(c) ~~Employee Welfare Benefit Plan 3.15(h~~Estimated Closing Statement 2.9(b) ~~Environmental Approvals 3.21(e~~Estimated Merger Consideration 2.9(b) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) Financial Statements 3.5 Governmental Body 3.4 HSR Act ~~6.2(a~~3.4 Independent Accounting Firm 2.10(c) ~~Indemnified D&Os 6.4(a~~Intellectual Property Assets 3.14(d) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Joinder Agreement Recitals Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) ~~Paying Agent Agreement 2.11(a~~Marks 3.14(d)(ii) ~~Payment Fund 2.11(a~~Merger Recitals Merger Consideration 2.2 Merger Sub Preamble Nonparty Affiliates 11.15 Patents 3.14(d)(i) Payoff Letters 2.8(a) Permits 3.17(a) Personal Information 3.14(d) Post-Closing Plans 6.6(b) Pre-Closing Period ~~6.1 Preliminary Closing Balance Sheet 2.17(a~~5.1(a) ~~Preliminary Closing Statement 2.17(a~~Projections 9.3(b) ~~Prior Merger Agreement~~ Protest Notice 2.10(c) Real Property Lease 3.12(c) Releasee 6.4(d) Releasor 6.4(d) Requisite Stockholder Approval Recitals RSU Holders 2.9(b) Schedules 11.2 Seller Representative Preamble ~~Related Agreements 3.5(a~~Significant Contracts 3.13 Significant Customer 3.19(a) ~~Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b~~Significant Supplier 3.20(a) Stockholder ~~Approval 3.8~~ Consent Recitals Stockholder ~~Meeting 5.8(b~~Debt Amount 2.2(d) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Surviving Company Recitals Tax Returns 3.10(a) ~~Survival Date 10.3(a~~Taxes 3.10(a) Taxing Authority 3.10(a) Third Party ~~Claim 10.4(b~~Rights 3.14(a)(iii) ~~Working Capital Deficit 2.17(f~~Trade Secrets 3.14(d)(iv) ~~Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f)~~Waived 280G Benefits 5.4

Appears in 1 contract

Sources: Merger Agreement (Concentrix Corp)

Additional Defined Terms. ~~The following~~ In addition to the terms defined in Section 1.1, additional defined terms used herein shall have the respective meanings ~~set forth on~~ assigned thereto in the ~~pages of this Agreement~~ Sections indicated below~~: 280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble~~ . Defined Term Section Agreed Claims ~~10.4(g~~8.6(d) Agreement Preamble ~~Agreement~~ Allocation 3.2(a) Anti-Corruption Laws 4.8(b) Assumed Liabilities 2.3 Canadian JV End Date ~~Preamble Allocation~~ 6.10(b) Claim Certificate ~~6.8 Antitrust Filings 6.2(a~~8.6(a) ~~Audited Balance Sheet 3.9(b~~Closing 3.3(a) ~~Audited Balance Sheet Date 3.9(b~~Closing Amount 3.1(a) ~~Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4~~ Closing Date ~~2.4 Closing Working Capital Estimate 2.17(a~~3.3(a) ~~Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e~~Collateral Source 8.5(a) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(fControlled Registered IP 4.12 Effect 1.1 End Date 9.1(b)(ii) Escrow ~~Agent 2.16~~ Account 6.10(c) Escrow Agreement ~~2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b~~3.1(b) ~~FDA Requirements 3.19(a)~~ Excluded Assets 2.2 Excluded Liabilities 2.4 Final ~~Working Capital 2.17(e) Firm 11.9 FTC 6.2(a~~Reconciliation 2.7(a) Fundamental Representations ~~10.2(a)(ii~~8.1 General Cap 8.4 Guarantor Recitals Icon NY Preamble Iconix Latin America Preamble Indemnified Party 8.6(a) ~~HSR Act 6.2(a~~Indemnifying Party 8.6(a) ~~Indemnified D&Os 6.4(a~~JV Asset Amount 3.1(b) ~~Indemnified Parties 10.1(a~~JV Asset Closing 2.6(b) (a) ~~Interim Balance Sheet 3.9(b~~JV Business 6.2(b) ~~Interim Balance Sheet Date 3.9(b~~JV Liabilities 6.10(a) ~~Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter~~ Knowledge of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent 1.5 Knowledge of Purchaser 1.5 Knowledge of Sellers 1.5 Limited Guaranty Recitals Parent Preamble ~~Parent Closing Balance Sheet 2.17(c~~AMERICAS 92199813 (2K) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre~~-8- Post-Closing ~~Period 6.1 Preliminary~~ Acquisition 6.10(a) Post-Closing ~~Balance Sheet 2.17(a~~Acquisition End Date 6.10(b) ~~Preliminary Closing Statement 2.17(a~~Purchase Recitals Purchase Price 3.1 Purchased Assets 2.1 Purchaser Preamble Purchaser Disclosure Letter Article V Purchaser Indemnitees 8.2 Remaining JV Escrow Amount 6.10(b) ~~Prior Merger Agreement Preamble Related Agreements 3.5(a~~Royalties 2.7(a) Seller ~~Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii~~Indemnitees 8.3 Sellers Preamble Sellers Disclosure Letter Article IV Sharper Image Holdings Preamble Synthetic Acquisition 6.10(b) ~~Specified Representations 10.2(a)(iii) ▇▇▇▇▇ Law 3.12(b) Stockholder Approval 3.8 Stockholder Meeting 5.8(b) Straddle Period 1.1 Subsidiary Securities 3.2(b) Survival Date 10.3(a) Third~~ Top Licensees 4.13 Third-Party Claim ~~10.4(b~~8.7(a) ~~Working Capital Deficit 2.17(f) Working Capital Objection Period 2.17(e) Working Capital Objection Statement 2.17(e) Working Capital Surplus 2.17(f~~Transfer Taxes 6.7(a)

Appears in 1 contract

Sources: Asset Purchase Agreement

Additional Defined Terms. ~~The~~ For purposes of this Agreement and the Ancillary Agreements, the following terms ~~shall~~ have the meanings ~~set forth on~~ specified in the ~~pages~~ indicated Section of this ~~Agreement indicated below~~Agreement: ~~280G Approval 6.3(c~~Adjustment Calculation 2.7(a) ~~280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Adjustment Notice 2.7(a) Agreement Preamble Assignment and Assumption Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.10(a) ~~Audited~~ Assumed Liabilities Section 2.3 Balance Sheet ~~3.9(b~~3.5(a) ~~Audited Balance Sheet Date 3.9(b~~▇▇▇▇ of Sale 2.10(a) ~~Audited Financial Statements 3.9(b~~Claim Notice 9.3(a) ~~California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1~~ Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent 2.9 Closing Balance Sheet ~~2.17(c~~2.7(a) ~~Parent Representatives 5.9 Parent Working Capital Determination 2.17(c~~Closing Date 2.9 COBRA 3.16(c) ~~Parent Working Capital Statement 2.17(c~~Competing Activity 8.7(a) ~~Paying Agent 2.11(a~~Consulting Agreement 2.10(a) ~~Paying Agent Agreement 2.11(a~~Controlling Party 9.4(c) ~~Payment Fund 2.11(a~~Dispute Notice 2.7(b) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iiiDOL 3.16(b) ▇▇▇▇▇▇▇ ~~Law 3.12(b~~Money Deposit 2.13(b) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Employment Agreements 2.10(a) (a) ~~Straddle Period 1.1 Subsidiary~~ Escrow Agent 2.10 (a) Estimated Balance Sheet 2.6(a) Estimated Closing Net Working Capital 2.6(a) Excluded Assets 2.2 Excluded Liabilities 2.4 Final Closing Net Working Capital 2.7(a) Financial Statements 3.5(a) Hired Employee 8.12(a) Improvements 3.12(d) Indemnified Party 9.3(a) Indemnifying Party 9.3(a) Independent Accounting Firm 2.7(d) Initial Purchase Price 2.2 Interim Balance Sheet 3.5(a) Leased Real Property 2.1 Multiemployer Plan 3.16(c) Noncontrolling Party 9.4(c) Objection Notice 9.3(b) Owned Intellectual Property 3.13(a) Owned Real Property 2.1(a) Pension Plan 3.16(b) Permitted Exceptions 5.7(c) Purchase Price 2.7(h) Purchased Assets 2.1 Purchaser Disclosure Schedule Article 4 Purchased Intellectual Property 2.1 Purchaser Preamble Purchaser Indemnified Party 9.1 Qualified Plan 3.16(b) Real Property Permits 3.12(f) Recorded Documents 5.7(a) Restricted Persons 8.4(b) Securities ~~3.2(b~~Act 3.4(d) ~~Survival Date 10.3(a~~Seller Preamble Seller Disclosure Schedule Article 3 Seller Real Property 3.12 Members Preamble Selling Parties Representative 10.1 Special Claim 9.4(b) Survey 5.7(a) Tangible Personal Property 2.1 Third Party ~~Claim 10.4(b~~Intellectual Property 3.13(b) ~~Working Capital Deficit 2.17(f~~Title Commitment 5.7(a) ~~Working Capital~~ Title Cure Period 5.7(c) Title Defect 5.7(c) Title Insurer 5.7(a) Title Objection ~~Period 2.17(e~~Notice 5.7(c) ~~Working Capital Objection Statement 2.17(e~~Title IV Plan 3.16(c) ~~Working Capital Surplus 2.17(f~~Transfer Taxes 8.1(a)

Appears in 1 contract

Sources: Asset Purchase Agreement (Nova Biosource Fuels, Inc.)

Additional Defined Terms. The following terms ~~shall~~ have the ~~meanings~~ meaning assigned to such terms in the Sections of the Agreement set forth ~~on the pages of this Agreement indicated~~ below: ~~280G Approval 6.3(c) 280G Payments 6.3(c) Acquisition Proposal 5.11 Acquisition Sub Preamble Agreed Claims 10.4(g~~Accounting Firm 2.5 Acquired Assets 2.1(a) Agreement Preamble Allocation Schedule 2.7 Assumed Contracts 2.1(a)(i)(D) Assignment and Assumption Agreement ~~Date Preamble Allocation Certificate 6.8 Antitrust Filings 6.2(a~~2.8(b)(vi) ~~Audited Balance Sheet 3.9(b~~Assumed Liabilities 2.1(c) ~~Audited Balance Sheet Date 3.9(b~~Bank 2.8(b)(xii) Audited Financial Statements 3.9(b) California Stockholder Approval 3.8 Certificate of Merger 2.4 Claims 10.4 CLIA 1.1 Closing 2.4 Closing Date 2.4 Closing Working Capital Estimate 2.17(a) Company Preamble Company Board Approval 3.5 Company Certificate 2.10(e) Company Disclosure Schedule 3.0 Company Disclosure Schedules 3.0 Company Option 2.13(a) Company Preferred Stock 2.10(b) Company Representative 5.11 Company Software 3.18(l) Company Third Party Consents 6.3(b) Company Warrant 2.14(a) Company Warrant Documents 2.12(a) Confidentiality Agreement 5.9 Corporate Stockholder Approval 3.8 D&O Cap 6.4(b) Delivered Tax Returns 3.22(a) DGCL Preamble Disclosure Statement 5.8(a) Dissenting Shares 2.15 Dissenting Stockholders 2.15 DOJ 6.2(a) Effective Time 2.4 Employee Pension Benefit Plan 3.15(h) Employee Plan 3.15(h) Employee Welfare Benefit Plan 3.15(h) Environmental Approvals 3.21(e) Environmental Reports 3.21(f) Escrow Agent 2.16 Escrow Agreement 2.16 Escrow Fund 2.16 Estimated Working Capital Surplus 2.17(b) FDA Requirements 3.19(a) Final Working Capital 2.17(e) Firm 11.9 FTC 6.2(a) Fundamental Representations 10.2(a)(ii) HSR Act 6.2(a) Indemnified D&Os 6.4(a) Indemnified Parties 10.1(a) Interim Balance Sheet 3.9(b) Interim Balance Sheet Date 3.9(b) Interim Financial Statements 3.9(b) In-the-Money Company Option 2.13(a) In-the-Money Company Warrant 2.14(a) Leased Property 3.14(a) Letter Amendment Premable Letter of Transmittal 2.12(a) License Agreement 3.16(a)(xi) License Agreements 3.16(a)(xi) Majority Effective Time Holders 9.1(c) Measurement Date 1.1 Merger Preamble Option Cancellation Agreement 2.13(c) Organizational Documents 3.3 Out-of-the-Money Company Option 2.13(b) Out-of-the-Money Company Warrant 2.14(b) Outside Date 8.1(b) Parent Preamble Parent Closing Balance Sheet 2.17(c) Parent Representatives 5.9 Parent Working Capital Determination 2.17(c) Parent Working Capital Statement 2.17(c) Paying Agent 2.11(a) Paying Agent Agreement 2.11(a) Payment Fund 2.11(a) Pre-Closing Period 6.1 Preliminary Closing Balance Sheet 2.17(a) Preliminary Closing Statement 2.17(a) Prior Merger Agreement Preamble Related Agreements 3.5(a) Seller Group 11.19 Series D Stock 1.1 Special Representations 10.2(a)(iii) Specified Representations 10.2(a)(iiiPlans 3.16(b) ▇▇▇▇▇ ~~Law 3.12(b~~of Sale 2.8(b)(iv) ~~Stockholder Approval 3.8 Stockholder Meeting 5.8(b~~Business Recitals Closing 2.8(a) ~~Straddle Period 1.1 Subsidiary Securities 3.2(b~~Closing Date 2.8(a) ~~Survival Date 10.3(a) Third Party Claim 10.4(b)~~ Closing Statement 2.3 Closing Working Capital ~~Deficit 2.17(f~~2.3 Company Preamble Company Employment-Related Liabilities 5.2(d) ~~Working Capital Objection~~ Company Owned Software 3.12(a) Company’s Representations ARTICLE III Court Approval 2.8(a) Domain Name 3.22(a) Equipment 2.1(a)(i)(B) Escrow Agent 2.4 Escrow Agreement 2.4 Escrow Amount 2.4 Excluded Assets 2.1(b) Excluded Liability 2.1(d) Financial Statements 3.6(a) HK Purchaser Preamble Indemnification Period ~~2.17(e~~6.1 Intellectual Property Assignments 2.8(b)(viii) ~~Working Capital Objection~~ Intellectual Property Purchase Price 2.2(a) Inventory 2.1(a)(i)(A) ITA 2.2(d)(i) ITA Tax Ruling 2.2(d)(i) Leased Premises 3.9(b) Material Contract 3.13(a) Material Customers 3.21(a) Material Suppliers 3.21(b) OCS Approval 2.8(a) Other Assets 2.1(a)(i) Other Assets Purchase Price 2.2(a) Overlapping Entity 3.11(c) Overlapping Service Provider 3.11(c) Pakshi Purchaser Preamble Party or Parties Preamble Purchase Price 2.2 Purchaser Preamble Purchaser Employee 5.2(a) Purchaser Employment-Related Liabilities 5.2(e) Qualified Withholding Certificate 2.2(d)(ii) Records 2.1(a)(i)(H) Statement ~~2.17(e~~of Objections 2.5 Tax Incentives 3.18(p) ~~Working Capital Surplus 2.17(f~~Threshold 6.3(b)

Appears in 1 contract

Sources: Asset Purchase Agreement (Clearone Communications Inc)

Common use of Additional Defined Terms Clause in Contracts